Influence of Insulin Resistance on Contractile Activity-Induced Anabolic Response of Skeletal Muscle by Nilsson, Mats I.
  
 
 
INFLUENCE OF INSULIN RESISTANCE ON CONTRACTILE 
ACTIVITY-INDUCED ANABOLIC RESPONSE OF SKELETAL 
MUSCLE  
 
 
A Dissertation  
by 
MATS INGE NILSSON  
 
 
Submitted to the Office of Graduate Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of  
DOCTOR OF PHILOSOPHY 
 
 
December 2009 
 
 
Major Subject: Kinesiology  
 
  
INFLUENCE OF INSULIN RESISTANCE ON CONTRACTILE 
ACTIVITY-INDUCED ANABOLIC RESPONSE OF SKELETAL 
MUSCLE  
 
 
A Dissertation  
by 
MATS INGE NILSSON  
 
 
Submitted to the Office of Graduate Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of  
DOCTOR OF PHILOSOPHY  
 
Approved by: 
Chair of Committee,  James D. Fluckey  
Committee Members, John M. Lawler  
 Steven E. Riechman  
 Harry A. Hogan  
Head of Department, Richard B. Kreider  
 
December 2009 
 
Major Subject: Kinesiology  
 iii 
ABSTRACT 
 
Influence of Insulin Resistance on Contractile Activity-induced Anabolic Response of 
Skeletal Muscle. (December 2009)  
Mats Inge Nilsson, B.S., University of Alabama;  
M.S., University of Texas at El Paso 
Chair of Advisory Committee: Dr. James D. Fluckey 
 
Although the long-term therapeutic benefits of exercise are indisputable, contractile 
activity may induce divergent adaptations in insulin-resistant vs. insulin-sensitive 
skeletal muscle. The purpose of this study was to elucidate if the anabolic response 
following resistance exercise (RE) is altered in myocellular sub-fractions in the face of 
insulin resistance. Lean (Fa/?) and obese (fa/fa) Zucker rats were assigned to sedentary 
and RE groups and engaged in either cage rest or four lower-body RE sessions over an 
8-d period. Despite obese Zucker rats having significantly smaller hindlimb muscles 
when compared to age-matched lean rats, basal 24-h fractional synthesis rates (FSR) of 
mixed protein pools were near normal in distally located muscle groups (gastrocnemius, 
plantaris, and soleus) and even augmented in those located more proximally (P < 0.05; 
quadriceps). Although 2 x 2 ANOVA indicated a significant main effect of phenotype on 
mixed FSR in gastrocnemius and soleus (P < 0.05), phenotypic differences were 
partially accounted for by an exercise effect in the lean phenotype. Interestingly, obese 
rats exhibited a significant suppression of myofibrillar FSR compared to their lean 
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counterparts (P < 0.05; gastrocnemius), while synthesis rates of mitochondrial and 
cytosolic proteins were normal (gastrocnemius and quadriceps), suggesting a mechanism 
whereby translation of specific mRNA pools encoding for metabolic enzymes may be 
favored over other transcripts (e.g., contractile proteins) to cope with nutrient excess in 
the insulin-resistant state. Immunoblotting of the cytosolic fraction in gastrocnemius 
muscle indicated an augmented phosporylation of eIF4EBP1 (+ 9%) and p70s6k (+85%) 
in obese vs. lean rats, but a more potent baseline inhibition of polypeptide-chain 
elongation as evidenced by an increased phospho/total ratio of eEF2 (+78%) in the obese 
phenotype. Resistance exercise did not improve synthesis rates of myofibrillar, cytosolic, 
or mitochondrial proteins to the same extent in obese vs. lean rats, suggesting a 
desensitization to contractile-induced anabolic stimuli in the insulin-resistant state. We 
conclude that insulin resistance has diverse effects on protein metabolism, which may 
vary between muscle groups depending on fiber type distribution, location along the 
proximodistal body axis, and myocellular sub-fraction, and may blunt the anabolic 
response to voluntary resistance exercise.  
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CHAPTER I 
INTRODUCTION 
Epidemiology of Type 2 Diabetes 
Although the genetic makeup of homo sapiens sapiens has remained relatively 
unchanged over the past 10.000 years, our culture has been transformed almost beyond 
recognition during the same time period, leading to a mismatch between our genetically 
controlled biology and the bio-environmental milieu (38). The discordance between 
modern lifestyle factors (physical activity levels and quality of diet) and our ancient 
genome has undoubtedly contributed to the epidemic-like rise in chronic degenerative 
diseases (CDD), which currently account for ~75% of all deaths in developed nations 
(38). Exact etiologies of these debilitating diseases are in many cases unknown, but 
alterations of candidate genes (single nucleotide polymorphisms or mutations) and/or 
inherited epigenetic modifications may confer an increased susceptibility upon which 
bio-environmental factors act to regulate disease progression (38).    
  
 
 
 
 
 
 
 
 
 
 
 
____________ 
This dissertation follows the style of American Journal of Physiology Endocrinology 
and Metabolism. 
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Since the industrial revolution, the incidence of obesity and type 2 diabetes 
(henceforth also referred to as diabetes and T2DM) has increased concomitantly with the 
global spread of technology and affluence. Excessive consumption of calorie-
dense/nutrient-poor foods (i.e. Western-style diets) and physical inactivity are behaviors 
in stark contrast to the lifestyles led by our hunter-gatherer ancestors, and have caused 
ballooning waistlines all over the world. The World Health Organization currently 
estimates that over 1 billion adults are overweight (Body Mass Index [BMI] 25-29.99 
kg/m2) and at least 300 million of them are obese (BMI ≥30 kg/m2). In 1995 and 2001, 
the global prevalence of diabetes was ~135 million and ~170 million, respectively, and 
this number is projected to be ~300 million in 2025 (82), with the greatest increases in 
the developing countries of Africa, Asia, and South America. The total number of deaths 
attributed annually to diabetes is around 2.9 million (134) and diabetes mellitus alone 
claims on average around 8% of total healthcare budgets in developed countries (135). 
Direct healthcare costs associated with the metabolic syndrome, a cluster of medical 
disorders commonly co-expressed with type 2 diabetes, currently dominate Western 
healthcare budgets (137).  
The equivalent US statistics from 1999-2000 make equally grim reading 
considering that 14.4% of the population had impaired fasting glucose or 
diagnosed/undiagnosed diabetes [T2DM disease progression is defined in the next 
paragraph1] (19), 8.3% of the population was officially diagnosed with type 2 diabetes 
(19), and ~60% of the population was classified as either overweight or obese (46).  
Statistics from 1999-2002 indicate that ~65% of the US population was either 
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overweight or obese (62), and that the prevalence of obesity among US type 2 diabetics 
was 54.8% (20). The average weight gain over the last decade was estimated to be 0.45-
0.90 kg/yr (66), corresponding to a total increase in body weight of 4.5 kg (5.5 lbs)-9kg 
(20 lbs) per American. Considering that for every kilogram gained in body mass there is 
a linear increase in risk of diabetes and cardiovascular comorbidities such as coronary 
heart disease (CHD), the health implications of excessive weight gain is potentially life 
threatening.  In addition, conditions that predispose to overt diabetes, including impaired 
fasting glucose and glucose intolerance (and thus indirectly obesity), are not merely of 
academic interest, since, unless treated, ~7% of people with these problems will progress 
to type 2 diabetes every year (122). Approximately 1.3 million new US cases occur 
annually (i.e. incidence) and the total direct and indirect costs of treating diabetes, as 
estimated by the American Diabetes Association (ADA), exceed $130 billion per year.  
1Stage of disease is determined by A) Fasting venous plasma glucose test (FG; 
administrated after at least 8 hours fasting) and/or B) Oral glucose tolerance test (OGTT; 
measured 2 hours post glucose load in venous blood) as established by WHO in 1998 
and the American Diabetes Association in 2003 (1, 32).  If the fasting glucose 
concentration is in the diagnostic range for diabetes, an OGTT is not required for 
diagnosis, but a confirmatory test should be performed due to intraindividual variations. 
Normal glucose regulation can only be verified using both FG and OGTT since subjects 
with fasting glucose values below diagnostic criteria may exhibit impaired glucose 
tolerance. Insulin resistance is defined as a reduced responsiveness of a cell, an organ, or 
the whole organism to insulin concentrations to which it is exposed (112) and is 
 4 
generally present before any abnormalities in glucose regulation are detected. Insulin 
resistance is tightly coupled to plasma hyperinsulinemia with approximately twofold 
elevations in basal insulin concentrations in obese and/or type 2 diabetic patients (112).  
  
A) FG: Normal glucose regulation (<100 mg/dL; <5.5 mmol/L) → impaired glucose 
regulation (100-125 mg/dL; 5.6-6.9 mmol/L) → diabetes mellitus (≥126 mg/dL; 
≥7.0 mmol/L).  
B) OGTT: Normal glucose regulation (<140 mg/dL; <7.8 mmol/L) → impaired 
glucose regulation (140-199 mg/dL; 7.8-11.0 mmol/L) → diabetes mellitus 
(≥200 mg/dL; ≥11.1 mmol/L).  
 
Pathophysiology and Etiology of Type 2 Diabetes 
The defining pathophysiologies (i.e. biological manifestations of a disease) of 
T2DM include a chronic elevation in blood sugar and plasma insulin levels (i.e. 
hyperglycemia and hyperinsulinemia, respectively), increased plasma amino acid levels 
(hyperaminoacidemia), and elevated plasma, intra-organ, and cellular lipid levels 
(dyslipidemia). Although cause and effect mechanisms still remain elusive, it is believed 
that disturbances in carbohydrate, lipid, and to a lesser extent protein metabolism lead to 
insulin resistance and ultimately type 2 diabetes. The comorbidities typically associated 
with T2DM, in addition to hyperglycemia and hyperinsulinemia, are collectively 
referred to as the metabolic syndrome, which is a cluster of pro-atherogenic conditions 
including hypertension, dyslipidemia, and abdominal obesity.  It is estimated that 20% of 
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US adults suffer from the metabolic syndrome (51), and that these individuals are at a 
3.5 times greater risk of death from CHD, as well as an increased risk of liver and kidney 
disease, and possibly cancer. All in all, type 2 diabetics have a two- to fourfold increased 
risk of developing cardiovascular complications and a threefold increased risk of 
suffering a mortal stroke compared to healthy individuals. Even the less benign “pre-
diabetic” stages (impaired fasting glucose [IFG] and/or glucose intolerance) are strongly 
associated with cardiovascular disease (CVD) [including cerebrovascular and peripheral 
vascular disease], dyslipidemia, and various forms of cancer (61). Not surprisingly, 
micro- and macrovascular2 complications cause 70% of deaths in this population (57), 
where retinopathy, nephropathy, and neuropathy (i.e. microvascular complications) 
account for the majority of morbidity and mortality (75). An estimated ~40-70% of all 
non-traumatic amputations world-wide are performed in diabetics due to ulcerations of 
the lower limb, and an astounding 1200 amputations are performed every week among 
the 16 million US diabetics (17). Less benign manifestations of T2DM include polyuria 
(frequent urination), polydipsia (increased thirst and fluid intake), 
polyphagia/hyperphagia (overeating), gastroparesis (delayed gastric emptying), 
depression, impotence, and blurred vision.  
2Hypertension, atherosclerosis, arterial-wall stiffening/reduced compliance, 
coronary artery disease, endothelial dysfunction leading to increased permeability and 
decreased vasodilation (eNOS and tetrahydrobiopterin [BH4] levels decreased), arterial 
calcification, stenosis, thromboembolism, myocardial microangiopathy, 
cardiomyopathy, myocardial infarctions, aneurysms/hemorrhages/ruptures of 
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carotid arteries/vessels in brain, and peripheral vascular disease caused by ischemia, 
tissue damage, and inflammation.  
Significant advances have been made in type 2 diabetes research over the last 
100 years, but the etiology of the disease is ill-defined and cause-and-effect mechanisms 
remain elusive. Although there is a strong linear correlation between obesity and 
diabetes on an epidemiological level (20), and compelling evidence that disturbances in 
fat metabolism underlie many of the metabolic dysfunctions associated with the disease, 
the etiological reason(s) why most type 2 diabetics suffer from dyslipidemia and 
excessive adiposity remain unclear. Physical inactivity and consumption of calorie-
dense/nutrient-poor foods are undeniably key factors in the development of the 
metabolic syndrome, but both environmental and inheritable factors may contribute to 
the advancement of the disease. It has been estimated that ~10%  of type 2 diabetes cases 
are attributed to genetic factors (105), where single nucleotide polymorphisms (defined 
as occurring in >1% of the population), mutations (defined as occurring in <1% of the 
population), and/or epigenetic modifications of candidate genes collectively confer an 
increased susceptibility upon which environmental factors act to regulate disease 
progression (34). In other words, genes cock the gun and the environment pulls the 
trigger. There is indirect evidence that our genes are still programmed for the lifestyles 
associated with our historical ancestors (i.e. regular daily physical activity and 
consumption of the “stone-age diet”), and that the mismatch between the modern 
bioenvironment and the human genome sets the stage for the development of chronic 
degenerative diseases (38). The maladaptation between modern lifestyle factors and our 
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genetically controlled biochemistry have promoted a dramatic increase in incidence of 
chronic degenerative diseases since the industrial revolution (38). The effects of dietary 
factors and sedentary activity patterns account for about 365,000 deaths each year in the 
US and represent a leading contributor to death, second only to tobacco use (96).  
Although the global cause of the exponential increase in chronic degenerative 
diseases in modern times has been identified (hence CDDs are commonly referred to as 
life style-related disorders), organ and cellular level mechanisms are generally poorly 
defined. In the case of overt type 2 diabetes, there is strong evidence that hyperglycemia 
is caused by a decreased insulin sensitivity [e.g., insulin resistance] of target cells in 
peripheral/splanchnic tissues [primarily fat, muscle and liver cells] and/or insufficient 
insulin production due to a gradually declining pancreatic β cell function (Fig. 1).  
Pancreatic failure is indeed the last stage in the progression of type 2 diabetes, but it is 
believed that impaired substrate clearance by skeletal muscle and adipose tissue, and to a 
lesser degree over-secretion of substrate by hepatocytes and portal adipocytes, are the 
immediate physiological causes of the clinical manifestation of the disease [i.e. 
hyperglycemia] (86). In addition to a reduced uptake/increased release of fatty acids by 
adipocytes and decreased glucose disposal in skeletal muscle, type 2 diabetes is 
characterized by an increased postabsorptive (basal; fasting) hepatic glucose production 
(HGP) and a reduced ability of insulin to suppress HGP (i.e. hepatic insulin resistance) 
(103). The glucose released by the liver can be derived from either glycogenolysis or 
gluconeogenesis.  The mechanisms responsible for an increased hepatic gluconeogenesis 
in type 2 diabetics include hyperglucagonemia, increased circulating levels of 
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gluconeogenic precursors (lactate, alanine, glycerol), increased FFA oxidation, enhanced 
sensitivity to glucagon and decreased sensitivity to insulin. Although the majority of 
evidence indicates that a chronic elevation in gluconeogenesis is the major cause of the 
increase in HGP in type 2 diabetic subjects, it is likely that accelerated glycogenolysis 
also contributes. 
In healthy individuals, increased gluconeogenesis and glucose release is 
compensated by decreased glycogenolysis, due to concomitant hyperinsulinemia, 
increased levels of glucose-6-phosphate, and lipolysis-derived ATP (inhibition of 
glycogen phosphorylase and activation of glycogen synthase), thereby maintaining 
hepatic glucose output at an optimal level (so called hepatic autoregulation) (85). In 
obese individuals, chronically elevated serum free fatty acids (FFAs) and high insulin 
levels lead to increased FFA uptake by the liver and increased synthesis of lipids, 
resulting in hepatic triglyceride (TG) accumulation, which is accompanied by hepatic 
insulin desensitization caused by lipid-mediated activation of protein kinase C (33). 
Thus, lipid-induced breakdown of hepatic autoregulation may underlie the increase in 
hepatic glucose output and ultimately whole-body hyperglycemia in type 2 diabetics. 
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Fig. 1. The „four horsemen‟ of diabetes (pancreas, adipose tissue, liver, and skeletal muscle). Type 2 diabetes is associated with 
insulin resistance of target cells in peripheral/splanchnic tissues, collectively causing hyperglycemia and increased circulating 
levels of free fatty acids. An impaired insulin action on adipose lipoprotein lipase (LPL), hormone sensitive lipase (HSL) and 
triglyceride lipase (TGL) leads to an attenuated uptake but augmented release of non-esterified (free) fatty acids (FFA) into the 
blood stream. Chronically elevated plasma FFA levels lead to ectopic lipid deposition in the liver and augmented hepatic lipid 
oxidation followed by an increase in gluconeogenesis/glycogenolysis and release of glucose. A chronic increase in circulating 
FFAs also trigger intramuscular lipid accumulation and amplified lipid oxidation in skeletal muscles, which induces lipotoxicity 
(buildup of lipid intermediates such as ceramide and diacylglycerol [DAG]) and a reduction in glucose uptake by inhibiting 
insulin receptor signaling and GLUT-4 translocation. Pancreatic β-cells will initially augment insulin release in response to 
elevated plasma glucose levels in insulin-resistant individuals, but will gradually lose its ability to secrete the hypoglycemic 
hormone leading to overt type 2 diabetes and eventually β-cell failure.             
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Several theories regarding the etiology of insulin resistance have been proposed, 
all of which have support in literature. Prior do describing these theories it is important 
to mention that they are not mutually exclusive. According to the adipose tissue 
expandability hypothesis (52, 129), the capacity of an individual to expand their fat-mass 
to store lipid is a more important determinant of metabolic problems than absolute 
amount of adipose tissue. The failure to buffer lipid appropriately leads to elevated fatty 
acids and triglycerides, causing ectopic deposition of lipid (i.e. lipotoxicity) and insulin 
resistance in non-adipose organs such as liver, muscle, and pancreatic β-cells. The 
impaired adipose expandability hypothesis may explain the paradoxical finding that 
lipodystrophic individuals cannot accumulate fat, yet suffer from diabetes, dyslipidemia, 
and other metabolic complications. Further indirect support of this hypothesis can be 
seen in morbidly obese individuals who do not exhibit metabolic syndrome, indicating 
that they have yet to reach the point where they cannot expand their adipose tissue 
further. Another plausible theory pertains to an inherent or acquired mitochondrial 
deficiency (organelle number and/or function) causing a reduced capacity of organs to 
adjust lipid oxidation according to lipid bioavailability, which ultimately lead to ectopic 
fat deposition and lipid-induced toxicity in non-adipose tissues. Although not measuring 
substrate oxidation directly, Kelley and colleagues (2002) demonstrated that skeletal 
muscle mitochondria in type 2 diabetic and obese subjects are smaller and may exhibit 
impaired bioenergetic capacity compared to lean individuals (81). In contrast, more 
recent research in humans with T2DM and metabolic rodent models have suggested that 
impaired mitochondrial fatty acid oxidation does not account for an increased 
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intramuscular lipid content (15, 69). As a matter of fact, an elevated intramuscular lipid 
load, as observed in insulin-resistant rodent models (69), causes an elevation in fatty acid 
oxidation rates and improves mitochondrial density (69). It appears that when the rate of 
fatty acid transport across cytosolic and mitochondrial membranes exceeds the 
concurrently augmented capacity for mitochondrial oxidation (69), intramuscular lipids 
begin to accumulate and eventually cause damage in a time-dependent manner, possibly 
through oxidative stress (2, 12)  Indeed, high-fat diet initially induces an increase in 
mitochondrial biogenesis and fatty acid oxidative capacity, with deteriorations in 
mitochondrial structure and function occurring first after several months of high-fat 
feeding (12). Consequently, mitochondrial dysfunction may be a consequence rather 
than a cause of cellular perturbations in substrate metabolism in T2DM (12). Lastly, the 
metabolic inflexibility theory suggests that T2DM is associated with a reduced ability to 
adapt glucose/lipid oxidation rates in response to changes in substrate availability (54). 
For example, an impaired capacity of oxidative tissues to adapt rates of lipid oxidation to 
lipid supply may ultimately lead to an increased triglyceride storage [ectopic lipid 
deposition] and insulin resistance. Metabolic flexibility to a high-carbohydrate meal, 
defined as an increase in RQ post feeding, has consistently been shown to be impaired in 
T2DM subjects during euglycemic-hyperinsulinemic clamp conditions compared to lean 
individuals (54). In addition, metabolic flexibility to a high-fat meal, defined as a drop in 
RQ, has previously been shown to be significantly different between diabetic and 
weight-matched non-diabetic subjects, with diabetics exhibiting a higher RQ following 
feeding (79). Although metabolic flexibility to long-term diets (fat or carbohydrate) does 
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not appear to be impaired in insulin-resistant individuals when assessed several days 
after the onset of feeding, the speed of adaptation appears to be compromised in this 
population, ultimately causing an increased accumulation of fat and possibly insulin 
resistance (54). Other plausible theories of insulin resistance are discussed in detail 
elsewhere (122), and include genetic factors (mutations or single nucleotide 
polymorphins of candidate genes), glucose toxicity, inadequate expansion of pancreatic 
β cells in response to increased insulin demand, and accumulation of amyloid (amylin) 
deposits in pancreatic islets.      
Protein Metabolism and Type 2 Diabetes   
Approximately 50% of whole body protein is synthesized and stored in skeletal 
muscle, which is an insulin-sensitive tissue that accounts for ~30-40% of total body 
weight (65), and is responsible for ~90% of glucose uptake after intravenous glucose 
administration (114) and ~25% after oral glucose load (80). Over 50% of skeletal muscle 
tissue (54.9% for males and 57.7% females) is located in the lower extremity (74), with 
much of this muscle positioned in the thighs and buttocks. Considering that skeletal 
muscle is one of the major sites of insulin resistance due to its importance in insulin-
mediated glucose uptake, and that the lower body makes up >50% of total muscle mass, 
structural and functional maintenance of the larger muscle groups in the lower 
extremities may have clinical relevance for T2DM patients. Data from a recent NIH-
sponsored multicenter randomized clinical trial indicate that type 2 diabetics have an 
altered tissue distribution with an excess of fat and lean tissue in the truncal region and a 
deficit of fat and lean tissue in the leg region (65). The clinical significance of a reduced 
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lean mass in the lower body is unknown, but a larger thigh and hip circumference, 
leading to a lower waist to hip ratio (WHR), has been shown to be  associated with 
increased glucose tolerance on multiple occasions (116). Chowdhury and colleagues 
reported that differences in fasting glucose levels (FG) between age- and BMI-matched 
Indian and Swedish males (FG: 4.9 mmol/L and 4.5 mmol/L, respectively) were not due 
to differences in visceral fat, but rather a decreased muscle mass in the lower extremities 
of the former (24). Thus, despite exhibiting greater bodyweight, BMI, total fat mass, and 
total lean mass compared to healthy individuals, type 2 diabetics appear to have an 
altered lean mass distribution, which may act in parallel with insulin resistance to reduce 
glucose uptake and glycogen storage capacity of the lower body. Although the 
importance of maintaining lower body muscle mass compared to other muscle depots 
and the implications for whole body glucose tolerance in type 2 diabetics remain to be 
elucidated, indirect support of this notion may be provided by cross-sectional studies 
performed in the geriatric field. Age-related sarcopenia has repeatedly been shown to 
affect lower extremities more dramatically than upper extremities (74), and this loss 
parallels the progressive decline in glucose tolerance that begins in the third or fourth 
decade of life (30, 39).    
Despite substantial alterations in glucose/lipid metabolism and reduced lower 
limb lean mass, perturbations in protein metabolism appear to be subtle in the human 
T2DM condition. Although significant methodological variations exist between studies 
(tracer choice, age, glycemic status, and gender of subject) making it difficult to draw 
any definite conclusions, assessments of protein synthesis and degradation rates in large 
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proximal muscle groups (e.g., quadriceps) have indicated an increased turnover or no 
difference between insulin-resistant and insulin-sensitive individuals (9, 60). 
Considering that type 2 diabetes-related complications such as peripheral neuropathy 
and microvascular dysfunction preferentially affect more distal regions of the limb 
(110), future research should aim to assess protein turnover in muscle groups such as 
gastrocnemius, plantaris, and soleus.  Furthermore, despite subtle differences in the 
mixed protein pool, significant perturbations may still be present in cellular 
compartments of the muscle fiber that regulate substrate metabolism (mitochondria and 
cytosol) and energy utilization/muscle contraction (myofibrils). Glucose and lipid 
metabolism is ultimately dependent upon energy-demand, activation, and turnover of 
metabolic enzymes, and more research is needed to elucidate the individual 
contributions of each myocellular sub-fraction to the overall metabolic condition. Lastly, 
to fully understand the etiology of insulin resistance, efforts should be made to measure 
protein turnover over a 24-hour period without significantly perturbing circadian 
rhythms, sleep patterns, or normal nutrient intake.  
Insulin-regulated glucose uptake, storage, and protein anabolism operate through 
the same pathway (Fig. 2), and it would make intuitive sense if impaired glucose 
handling in T2DM is associated with perturbations in protein anabolism. As described in 
previous paragraphs, recent research indicates that the balance between free fatty acid 
(FFA) availability, cellular uptake, and lipid oxidation is perturbed in the insulin-
resistant state, which causes intramyocellular lipid accumulation and ultimately insulin 
resistance. The current theory on skeletal muscle insulin resistance is that an already 
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augmented lipid oxidation rate is unable to match an excess FFA uptake, which leads to 
an increased accumulation of lipid signaling intermediates (primarily diacylglycerol 
[DAG] and ceramide) and other lipid compounds (sphingolipids, eicosanoids, and 
phospholipids). These compounds interfere with insulin- and possibly contraction-
mediated signal transduction by activating serine/threonine kinases such as PKCθ, 
thereby altering myocellular and whole-body glucose metabolism and potentially protein 
anabolism/breakdown. Perturbations in the association of IRS-1/2 to the insulin receptor 
and subsequent docking of phosphatidylinositol 3-kinase (PI3K) to IRS-1/2 appears to 
be prevalent in conditions of insulin resistance regardless of tissue type,  leading to a 
decreased activation of protein kinase B (PKB/Akt).  Akt-mediated inhibition of AS-160 
[Akt-substrate 160; GTPase activating protein] is impaired in the insulin-resistant state, 
which maintains Rab proteins in GDP-bound states, and ultimately suppresses GLUT-4 
translocation to the plasma membrane leading to reduced glucose uptake. In regards to 
skeletal muscle growth and insulin resistance, downstream signaling of Akt remains 
largely unelucidated. Although purely speculative, guanine nucleotide exchange factor 
(GEF) eIF2Bε may be partially inhibited (serines 535 and 539 phosphorylated) due to a 
decreased Akt-mediated GSK-3 repression [e.g., serine 21(GSK-3 α) and serine 9 (GSK-
3β) becomes dephosphorylated]. Considering that obesity-induced insulin resistance is 
associated with an increased intramuscular branched chain amino acid concentration, at 
least in metabolic rodent models, a partial repression of eIF2Bε may be rescued by 
prevailing aminoacidemia and subsequent phosphorylation of serine 525. Nevertheless, 
due to an increased lipid-associated metabolic stress of the endoplasmic reiticulum, 
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activation and/or expression of PKR-like endoplasmic reticulum associated protein 
kinase (PERK) may be increased as a part of the unfolded protein response, which may 
lead to an inhibition of eukaryotic initiation factor eIF2 by keeping the α subunit 
phosphorylated (serine 51), ultimately preventing an interaction and GDP/GTP exchange 
between of eIF2 and eIF2Bε. This would reduce ternary complex formation, translation 
initiation, and potentially reduce myocellular protein synthesis rates.  mTOR/raptor 
[mammalian target of rapamycin/regulatory associated protein of mTOR] dependent 
serine/threonine phosphorylations of ribosomal protein S6 kinase (p70S6k) and total 
p70S6k expression has previously been shown to be up-regulated in type 2 diabetes, 
perhaps as a result of BCAA-induced  amino acid activation of mTOR. Phosphorylation 
state of the other major substrate of the mTOR/raptor complex, eukaryotic initiation 
factor 4E binding protein 1 (eIF4EBP1) would potentially be augmented due to 
aforementioned hyperaminoacidemia as well. This would in turn increase eIF4 
complexation with eIF4G and eIF4A (eIF4F complex), which ultimately would lead to 
an increased 7-methyl-guanosine cap dependent mRNA translation. Considering that 
activation of downstream mTOR substrates p70S6K and eIF4EBP1 may be elevated in 
the insulin-resistant state, regulatory steps downstream of translation initiation must be 
inhibited (e.g., peptide-chain elongation), particularly if T2DM is associated with a 
suppression of global protein synthesis rates.      
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Exercise and Type 2 Diabetes  
Similar to other life style-associated maladies, individuals who ultimately 
manifest overt T2DM pass through several clinical stages during the development of the 
disease, which may be reversed or halted with lifestyle modifications (diet and exercise) 
and/or pharmacological treatment. The bad news is that only ~50% of adults in the US 
engages in regular, leisure-time, physical activity [46.7% of women and 49.7% of men; 
(21)] and exercise adherence among clinical populations is generally poor outside 
clinical settings. Clearly, the development of cost-effective preventive and treatment 
strategies that increase long-term patient compliance must be considered of prime 
importance to reduce the economic burden and suffering associated with type 2 diabetes. 
Exercise, independent of caloric restriction and weight-loss, has proven to be an 
effective, low-cost, and non-pharmacological alternative to traditional diabetes 
medications (86). Regular physical activity has been shown to reduce the risk of 
Fig. 2. Insulin-regulated glucose uptake, storage, and protein anabolism.  
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developing diabetes with 30-50% in healthy individuals (8), slow/reverse the progression 
of impaired insulin resistance in high-risk populations (31, 101, 126), improve glycemic 
control in overt type 2 diabetics (14), and confer additional protection against 
cardiovascular complications. Across all ranges of glycemic status, aerobically fit men 
have lower age-adjusted all-cause death rates than their less fit counterparts (83). In a 
Finnish heart disease risk factor study, men with maximal oxygen uptake (VO2max) of 
≤ 25.8 ml /kg/min were more than four times as likely to develop diabetes than men with 
VO2max of ≥31.1 ml/kg/min after adjustment for BMI, baseline blood glucose, and 
other covariates (93). Several studies have confirmed an inverse correlation between 
aerobic fitness levels and incidence of cardiovascular events as well as relative risk for 
all-cause mortality in populations suffering from obesity, impaired fasting glucose, 
and/or overt diabetes (86, 131). Thus, there is compelling evidence that higher levels of 
cardiorespiratory fitness confers substantial protection against all-cause mortality, 
macrovascular disease, and type 2 diabetes in diverse populations with various degrees 
of insulin resistance (86). 
Life style interventions (dietary modifications and exercise) have been shown to 
play a more substantial role in the prevention of type 2 diabetes in insulin-resistant 
individuals compared to traditionally used pharmacological agents (31). The American 
Diabetes Prevention Program reported that a lifestyle-modification program, with the 
goals of at least a 7 percent weight loss and at least 150 minutes of physical activity per 
week, reduced the incidence of diabetes by 58% and 27% compared to placebo and 
metformin, respectively, in an at-risk population (31). Although, metformin is one of the 
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most frequently prescribed drugs in the country overall and is the most popular anti-
diabetic drug, recent research suggests that it may inhibit complex I of the electron 
transport system and impact aerobic capacity negatively (16).  
A recent meta-analysis of 14 well-controlled randomized studies showed that 2 to 
12 months of resistance and/or endurance exercise over a range of intensities improves 
glycemic control ( ~0.6% decreases in glycated hemoglobin; HbA1c), reduces visceral 
and subcutaneous adipose tissue while maintaining bodyweight, decreases plasma 
triglycerides, and increases insulin sensitivity in type 2 diabetics (124). The aerobic 
exercise interventions, which, on average, consisted of three 53-min session per week of 
walking or cycling over an 18-wk period, were associated with a mean 0.67% reduction 
in HbA1c levels, while resistance training (2-3 sets ranging from 10-20 repetitions at 
50% of respondents‟ repetition maximum) yielded a comparable reduction of 0.64%.  
An exercise-induced reduction of 0.6% HbA1c compares well with monotherapy of 
pharmacological agents such as biguanides, more specifically metformin, 
sulphonylureas, meglitinides, alpha-glucosidase inhibitors, DPP-4 inhibitors, and may be 
more effective than certain thiazolidinediones. Stratton et al. (2000) reported that a 1% 
rise in glycated hemoglobin represents a 21% increase in risk for any diabetes-related 
death, a 14% increased risk for myocardial infarction, and a 37% increased risk for 
microvascular complications (120). Although the decreases in HbA1c through physical 
activity are substantial and are likely to markedly reduce the risk of diabetes-related 
complications, the optimal type, frequency, intensity, and duration of exercise for 
achieving these therapeutic goals are not known (124).  
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The American Diabetes Association, American Cancer Society, and American 
Heart Association advocate 0.5 hour/day of moderately intense exercise for the 
prevention of type 2 diabetes, CVD, and some types of cancer (40). Although raising the 
bar even higher may erode the motivation of chronically sedentary populations, there is 
strong evidence that intensity of exercise may be an important factor to enhance glucose 
homeostasis and ultimately prevent diabetes and CVD. Because long-term compliance 
remains a challenge for adult fitness and rehabilitation/intervention programs, which are 
traditionally based on aerobic endurance training, regular resistance exercise (RE) may 
provide a means for maintaining interest and increasing adherence. Nevertheless, studies 
in men suggest that vigorous exercise is associated with even greater reductions in risk 
of CVD than is moderate-intensity exercise (8). For example, each 1-MET (3.5 ml 
O2/kg/min) increase in exercise intensity was associated with a 4% reduction in CHD 
risk independent of total exercise energy expenditure (123). Furthermore, it has been 
postulated that 2500-2800 kcal/wk (60-90 min/ day of moderate-intensity physical 
activity) may be required to maintain substantial loss of weight, which is an important 
goal in lifestyle modification programs for most type 2 diabetics. Exercise is often 
prescribed concurrently with caloric restriction in order to produce an energy deficit of 
500-1000 kcal/day while maintaining lean mass and basal metabolic rate (66).  
 
 
 
 21 
LaMonte and colleagues (2005) reviewed some of the acute and chronic 
exercise-induced muscle and systemic adaptations that enhance glucose homeostasis and 
confer protection against diabetes (86). Acute responses to exercise are immediate 
improvements in glucose uptake, transport, and/or disposal, but may be augmented with 
repeated bouts of exercise. Chronic adaptations to exercise include structural changes to 
the cardiovascular and musculoskeletal systems and require regular exposure to exercise 
to occur. Recent research has indicated that the acute anabolic response to contractile 
activity is blunted in the insulin resistant state. Although exercise has previously been 
shown to reduce whole-body glycosylated hemoglobin (HbA1c) levels to a similar extent 
traditional diabetes medications (124), recent reports suggests that differences exist 
between normal and insulin-resistant skeletal muscle in their adaptation to mechanical 
loading (78, 95, 125), and that insulin resistance may blunt the anabolic response to 
resistance-type exercise (59, 77, 119).   
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CHAPTER II 
CONTRACTILE ACTIVITY-INDUCED ANABOLIC RESPONSE IS 
ATTENUATED IN INSULIN-RESISTANT SKELETAL MUSCLE 
Introduction 
Since the industrial revolution, the incidence of life style-related diseases has 
increased concomitantly with the global spread of technology and affluence.  Excessive 
consumption of calorie-dense/nutrient-poor foods and physical inactivity are behavioral 
patterns strongly associated with the development of obesity and type 2 diabetes 
(T2DM), which are rare conditions in cultures whose essential features mimic those of 
our hunter-gatherer ancestors (38). One of the first maladies associated with obesity is 
skeletal muscle insulin resistance, currently believed to be attributed to an increased 
accumulation of intracellular lipid metabolites (e.g., fatty acyl-CoA, diacylglycerol, and 
ceramide) that antagonize insulin action via activation of serine/threonine kinases and 
phosphorylation of IRS1 (67, 132, 141). Acquired or inherited mitochondrial deficiency, 
more specifically a reduction in the number or intrinsic function of the organelle, has 
been postulated to decrease the capacity to oxidize fat, causing a net lipid accumulation 
and insulin resistance in various metabolic disease conditions (92). This notion has been 
questioned lately (68), and recent research suggests that impaired mitochondrial fatty 
acid oxidation does not account for an increased intramuscular lipid content (15, 69). As 
a matter of fact, an increased intramuscular lipid load, as observed in insulin-resistant 
rodent models (69), causes an elevation in fatty acid oxidation rates and improves 
mitochondrial density (69).      
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Insulin resistance is associated with profound alterations in lipid and 
carbohydrate metabolism and has been linked to a down-regulation of Akt/mTOR 
growth signaling cascades (e.g. regulation of protein synthesis) in both humans and 
rodents. Although perturbations in basal state whole-body protein metabolism appear to 
be subtle in the human condition (9, 60), there are substantial methodological variations 
between studies (tracer choice, age, glycemic status, and gender of subject), making it 
difficult to draw any definite conclusions. Assessments of protein synthesis and 
degradation rates in large proximal muscle groups (e.g., quadriceps) in type 2 diabetics 
have indicated an increased turnover or no significant differences between insulin-
resistant vs. insulin-sensitive skeletal muscle (9, 60). Considering that type 2 diabetes-
related complications such as peripheral neuropathy and microvascular dysfunction 
preferentially affect more distal regions of the limb (110), future research should aim to 
assess protein turnover in muscle groups such as gastrocnemius, plantaris, and soleus.  
Furthermore, despite subtle differences in the mixed protein pool, significant 
perturbations may still be present in cellular compartments of the muscle fiber that 
regulate substrate metabolism (mitochondria and cytosol) and energy utilization/muscle 
contraction (myofibrils). Glucose and lipid metabolism is ultimately dependent upon 
energy-demand, activation, and turnover of metabolic enzymes, and more research is 
needed to elucidate the individual contributions of each myocellular sub-fraction to the 
overall metabolic condition.  
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At the turn of the 20th century, the economic burden of chronic diseases was 
estimated to be a mind-boggling 1 trillion dollars/year (13), with 35.3% of the US 
population exhibiting type 2 diabetes or impaired fasting glucose (25), 5.9-6.3% of the 
population had previously diagnosed T2DM (19, 25), and a staggering 65.7% of the 
population was classified as overweight or obese (62), including a 54.8% prevalence of 
obesity among type 2 diabetics (20).  Clearly, the development of cost-effective 
interventions to delay or prevent the global obesity/diabetes pandemic must be 
considered of primary importance to improve health and relieve the burden of healthcare 
costs. Considering that type 2 diabetes is associated with a reduced glucose storage 
capacity, muscle weakness, and cardiovascular dysfunction, alternative 
intervention/treatment strategies should optimally augment muscle mass, strength, and 
oxidative capacity. Exercise, independent of caloric restriction and weight-loss, has 
proven to be an effective, low-cost, and non-pharmacological alternative to traditional 
diabetes medications. Because long-term compliance remains a challenge for adult 
fitness and rehabilitation/intervention programs, which are traditionally based on aerobic 
endurance training, regular resistance exercise (RE) may provide a means for 
maintaining interest and increasing adherence. Although resistance training has 
previously been shown to reduce whole-body glycosylated hemoglobin (HbA1c) levels to 
a similar extent compared to chronic endurance exercise and traditional diabetes 
medications (124), recent reports suggests that differences exist between normal and 
insulin-resistant skeletal muscle in their adaptation to mechanical loading (78, 95, 125), 
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and that insulin resistance may blunt the anabolic response to resistance-type exercise 
(59, 77, 119).  
The main purpose of the current study was to determine if skeletal muscle insulin 
resistance affects the 24-h anabolic response (cumulative plasticity) of cellular sub-
fractions regulating metabolism (mitochondria and cytosol) and energy utilization 
(myofibrils). However, considering the paucity of information on insulin resistance and 
how it influences turnover rates of proteins in aforementioned compartments, a 
secondary goal was to characterize basal differences in protein synthesis rates between 
insulin-resistant and insulin-sensitive muscle. For these purposes we employed a novel 
primed-constant infusion method, centering on the use of deuterium oxide (2H2O) as a 
tracer [for review see (18, 35)], to assess 24-h cumulative protein synthesis of 
mitochondrial-, cytosolic-, and myofibrillar-rich fractions in proximal and distal muscle 
groups of sedentary and resistance exercised lean and obese Zucker rats. The primary 
event of obesity and insulin resistance is an increased food intake, irrespective of cause, 
making the obese Zucker rat, which carries a missense mutation in the leptin receptor 
gene, an almost ideal animal model for studying the effects of insulin resistance on 
protein synthesis. Similar to type 2 diabetic patients with metabolic syndrome, it exhibits 
hyperphagia (up to 19 wks of age), hyperinsulinemia, hyperleptinemia, 
hypertriglyceridemia, hypercholesterolemia, glucose intolerance, angiopathy, and 
neuropathy (99). The 2H2O method has a practical advantage in that animal or human 
subjects are not required to be in a post-absorptive state, which allows us to measure 
protein synthesis over long periods of time and ultimately get a more realistic assessment 
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of muscle anabolism in a free-living environment, thus, accounting for sleep, feeding, 
and 24-h fluctuations in hormone secretion. We report that cumulative fractional 
synthesis rates (FSR) of mixed proteins are suppressed in gastrocnemius and soleus 
muscles of obese Zucker rats, but significantly elevated in quadriceps muscle, indicating 
that the effects of insulin resistance on protein metabolism are diverse and dependent 
upon proximodistal location of the muscle group. We also provide evidence that protein 
synthesis rates are normal in myocellular compartments containing oxidative and 
glycolytic enzymes (e.g., mitochondria and cytosol) regardless of proximodistal location. 
Accordingly, the observed suppression in mixed protein synthesis rates in distal muscle 
groups are exclusively accounted for by a reduction in myofibrillar FSR, suggesting a 
preferential down-regulation of contractile proteins over metabolic enzymes. We 
surmise that rate-limiting steps in polypeptide elongation are more strongly inhibited in 
the obese phenotype, or that translational capacity and/or translational efficiency of 
specific mRNA pools are altered to cope with nutrient overload. Lastly, voluntary 
resistance exercise does not improve cytosolic, myofibrillar, or mitochondrial FSR to the 
same extent in obese vs. lean rats, which may be indicative of a blunted capacity to 
respond to contractile stimuli in the insulin-resistant state.
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Methods 
Animals 
 The obese Zucker rat exhibits similar dysfunctions in substrate metabolism that 
are present in type 2 diabetics with metabolic syndrome, making it a near ideal candidate 
for studying the effects of insulin resistance on protein turnover. Thus, thirty 4-mo-old 
male obese (fa/fa, Crl: ZUC-Leprfa/fa) and lean (Fa/?, Crl: ZUC-LeprFa/?) Zucker rats 
(Charles River Laboratories, Wilmington, MA) were individually housed in a climate-
controlled environment with a reversed 12:12-h light-dark cycle, having free access to 
water and standard commercial rat chow (Harlan 2016 Teklad Global) throughout the 
study period. Following 1 wk of acclimation, the rats were matched according to body 
composition (GE Lunar Prodigy DXA [small animal software]; total body-, lean-, fat-, 
and bone-mass) within each phenotype and thereafter grouped into sedentary (Fatty-SED 
[FS; n = 6], Lean-SED [LS; n = 8]) and resistance exercised (Fatty-RE [FE; n = 8], 
Lean-RE [LE; n = 8]) cohorts (Fig. 3). As expected, obese rats had a significantly higher 
% fat and bone mass compared to the lean phenotype (P < 0.001), while exhibiting 
significantly depressed % lean mass (P < 0.001). No differences in DXA-derived 
parameters were present between experimental conditions within phenotypes.  
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Fig. 3. Body composition of lean (Fa/?) and obese (fa/fa) Zucker rats (dual energy X-ray absorptiometry scans [DXA]). Animals (n = 30) were 
matched according to lean body mass within each phenotype and grouped into sedentary (lean sedentary, LS [n=8]; fat sedentary, FS [n=6]) and 
resistance exercised (lean resistance exercised, LE [n=8]; resistance exercised, FE [n=8]) cohorts. Total body mass, bone mineral content, or fat 
mass were significantly higher in obese vs. lean rats (P < 0.001), while muscle mass was significantly lower (P < 0.001). Bars/groups sharing the 
same letter are not significantly different in any of the aforementioned outcome parameters (P > 0.05). Values are expressed in grams (g; y-axis) 
and relative to total body mass (%, within bars), and presented as means ± standard error (SE).      
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Experimental protocol 
For this study, we employed a well-established (42-45, 48, 49, 56, 63, 97, 133) 
voluntary resistance exercise (RE) paradigm to induce an anabolic response in protein 
sub-fractions of rat skeletal muscle. Although this 4-d progressive RE protocol can be 
considered “acute” since it does not result in appreciable changes of muscle mass, rates 
of protein synthesis in mixed gastrocnemius typically remain elevated 24-h post exercise 
(63). We have previously shown that this type of voluntary exercise increases bone mass 
in healthy rats (97, 133) and posterior crural muscle mass in insulin-deficient animals 
(44) if applied chronically. Despite a „minimalistic approach‟ when it comes to the 
effective exercise duration (~2.5 min/session), the high work intensity (~75 reps/session 
at 105-175% BW) emphasizes muscular endurance and may promote mitochondrial 
adaptations. Since obesity-induced insulin resistance has been coupled to mitochondrial 
dysfunctions, an in vivo voluntary RE paradigm that induces mitochondrial growth may 
be favorable over other commonly used RE protocols when studying metabolic 
disorders.  
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We realize that direct electrical stimulation (E-STIM) of the lower limbs may 
provide better control over force production, however, the drive for muscle contraction 
does not begin in the brain in E-STIM protocols making them hard to compare to the 
voluntary lifting regimens performed by humans. Furthermore, the administration of 
anesthesia during simulated resistance exercise affects skeletal muscle contractility (72), 
compromises cardiopulmonary function (29), and may alter blood flow to and from 
working muscles, which may be particularly problematic when assessing protein 
turnover in metabolic models already exhibiting cardiovascular and neural dysfunctions. 
Compensatory hypertrophy models, such as synergistic ablation or synergistic 
denervation, are effective in inducing muscle growth by increasing satellite cell 
incorporation (myonuclei addition) into myofibers, but may not be reflective of the 
anabolic response to voluntary exercise (107).        
Briefly, after a 1-wk acclimation period, RE cohorts were conditioned in a dark 
room to depress an illuminated bar in a Plexiglas exercise cage while wearing a Velcro 
vest adjustable for progressive increases in weights. Negative reinforcement via an 
electrical foot shock (< 2 mA, 60 Hz) was used to train the animals to perform the 
desired movement, which closely mimics a traditional leg squat as performed by 
humans, and requires full extension of hind legs and activation of associated muscle 
groups (mainly quadriceps and gastrocnemius complexes).  
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To account for possible confounding effects of negative reinforcement and 
handling on muscle metabolism, the sedentary cohorts wore the same Velcro vest and 
received the same average number of foot shocks as exercised animals, but without 
performing the actual exercise. In our experience, the obese rats mastered the movement 
pattern equally fast compared to their lean counterparts and did not require an altered 
absolute exercise intensity or increased shock-frequency. Following six operant 
conditioning (OC) sessions over 2 weeks, entrained rats of both phenotypes underwent a 
voluntary lower-body resistance exercise paradigm, consisting of four progressive 
sessions separated by either 48 h (RE1-RE3) or 72 h (RE3-RE4) [Fig. 4]. The RE 
cohorts performed the same number of sets and repetitions per weight (5 sets/session; 50 
reps RE1, 68 reps RE2, 84 reps RE3, and 92 reps RE4;) and were allowed 2 seconds of 
rest between reps and 2 minutes of rest between sets. Weights were progressively 
increased throughout each session (30-230 g RE1; 80-230 g RE2; 80-230g RE3; and 80-
280 g RE4) and the total amount lifted increased from 5500 g (RE1) to 15460 g (RE4). 
In accordance to previously published work using this exercise model in rats (42), the 
final bout (RE4) was completed 16 h prior to muscle harvest (4:30-5:00 PM). 
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Fig. 4. Schematic display of the study design. After one week of acclimation, rats in RE groups were operantly conditioned to perform a squat-like movement while 
wearing a Velcro vest adjustable for progressive increases in weights. All entrained rats underwent the same resistance exercise paradigm with minimal negative 
reinforcement, which consisted of four progressive sessions separated by either 48 h (RE1-RE3) or 72 h (RE3-RE4). The final exercise bout (RE4) was completed 16 h 
prior to muscle harvest. To measure cumulative muscle protein synthesis, an intraperitonal 99.9% 2H2O bolus injection was administered 24 h prior to sacrifice, and 4% 
2H2O was provided ad libitum in the drinking water throughout the last day.     
 
 33 
To measure cumulative protein synthesis in skeletal muscle of sedentary and 
trained cohorts, an intraperitoneal (IP) 99.9% 2H2O bolus injection (20ul/g BW) was 
administered to each animal 24 h prior to sacrifice (08:30-09:00 AM, 8 hours prior to 
last exercise session), and 4% 2H2O was provided ad libitum in the drinking water 
throughout the last day. Rat chow was withdrawn 4 hours prior to muscle harvest (04:30-
5:00 AM). On the morning of sacrifice (08:30-09:00 AM), the 5-mo-old rats were 
anesthetized with ketamine hydrochloride (Ketaset; 37.5 mg/kg BW) and medetomidine 
(Domitor; 0.25 mg/kg BW) via IP route. Two mL of whole blood were collected by 
cardiac puncture followed by quick excision of quadriceps and posterior crural muscle 
groups (mixed gastrocnemius, soleus, and plantaris) prior to euthanasia. Fat, blood, and 
connective tissue were removed from muscles before snap-freezing in liquid nitrogen, 
pulverization, and storage at -80°C.  
Measurement of  
2
H enrichment in body water 
As with all precursor-product labeling methods, the assessment of protein 
synthesis using heavy water requires reliable quantification of 2H enrichment of the 
precursory pool (i.e. body water/plasma). 2H-labeling of body water (EBW) was measured 
by gas chromatography-mass spectroscopy (Agilent 7890 GC/5975 VL MSD) following 
24-h isotopic exchange between 2H-enriched plasma samples and acetone, a method 
allowing for as low as 0.008% 2H enrichments of body water to be assayed (140). 
Briefly, 20 uL of calibration standards (0-5% 2H2O, prepared by mixing naturally 
labelled water with 99.9% 2H2O) or plasma samples were allowed to react for 24 hours 
at room-temperature with 2 uL of 10N NaOH and 4uL of a 5% (v/v) solution of acetone 
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in acetonitrile. After the 24-h incubation period, the solution was extracted by adding 
0.5g of Na2SO4 followed by 600 ul of chloroform and vigorous vortex. A small aliquot 
(50-100 µL) was transferred to a GC/MS vial and automatically injected (1 µL) into an 
Agilent 7890A GC system, volatilized, and separated on a capillary column (HP-5ms, 30 
m x 0.25 mm x 0.24 µm) using helium as the carrier gas (1 µL/min) at a 40:1 split ratio. 
The GC injector temperature was set at 220°C and the transfer line was held at 220°C. 
The initial temperature of the column program was 60°C followed by an increase of 
20°C/min to 100°C, which was further increased to 220°C at a rate of 50°C/min and held 
constant for 1 min. Acetone eluted from the column ~1.7 min post injection and was 
ionized with an Agilent 5975C VL MSD operating in electron impact mode using an 
ionization energy of 70eV. Selective ion monitoring (SIM) of mass to charge ratios (m/z) 
58 (M) and 59 (M+1) using a dwell time of 10 ms/ion were conducted after autotune. 
Peak abundances of ions 58 and 59 were extracted from chromatograms and M+1/M 
ratios were used to calculate % enrichment of body water based on a linear regression 
formula generated by deuterium oxide standards (R2 = 0.999). 2H-labeling of body water 
was readily detected in both phenotypes (3.04 ± 0.11%; mean ± SE), with an average of 
3.05 ± 0.17% in sedentary groups and 3.04 ± 0.15% in resistance exercised groups. All 
plasma samples were measured twice (prepared on two separate occasions) and an 
average value of the two runs was used for all calculations.  
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Measurement of  
2
H enrichment in skeletal muscle 
Enrichments of mixed, myofibrillar-, cytosolic-, and mitochondrial-rich fractions 
in quadriceps, gastrocnemius, and plantaris/soleus (mixed only) were determined by 
measuring protein-bound 2H-alanine (EA) as described by Dufner et al. (36). Pulverized 
mixed muscle (30 mg) or isolated sub-fractions (obtained from 100 mg mixed muscle) 
were homogenized in 0.3 mL of a 10% (w/v) TCA solution and centrifuged at 800 x g 
for 15 min at 4°C. For each sample, the supernatant was discarded and the pellet was 
centrifuged and washed three additional times in TCA to remove unbound amino acids. 
After the wash steps, the protein-rich pellet was hydrolyzed for 24 hours in 6N HCl at 
110°C (~0.13 mL/0.01g tissue; 400 µL for all fractions except mitochondria [200 µL]). 
An 100 µL aliquot of the hydrolysate (50 µL for mitochondria) was dried down for 1 
hour at 110°C and thereafter derivitized with a 3:2:1 (vol:vol:vol) solution of methyl-8, 
methanol, and acetonitrile for 1 hour at 70°C (1 µL/1 µL hydrolysate). The resulting 
methyl-8 /2H-alanine derivative was transferred to a GC/MS vial and analyzed with an 
Agilent 5975C VL MSD equipped with an Agilent 7890A GC system (HP-5ms capillary 
column, 30 m x 0.25 mm x 0.24 µm) to determine 2H-labeling of protein-bound alanine. 
The initial temperature of the column program was set at 90°C and held for 5 min, 
increased by 5°C/min to 130°C, which was further increased at a rate of 40°C/min to 240 
°C and held for 5 min, all steps performed at a constant helium flow of 1 mL/min. Peak 
abundances of ions 99 and 100 were extracted from chromatograms and M+1/M ratios 
were used to calculate % enrichment of protein-bound alanine using a regression 
formula generated by 2H-alanine standards (R2 = 0.999). 2H-labeling of alanine were 
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readily detected in all sub-fractions using a 20:1 split ratio for mixed proteins, 10:1 split 
ratio for myofibrillar and cytosolic proteins, and 5:1 split ratio for mitochondrial 
proteins. All samples were analyzed three times, which included complete re-preparation 
of the frozen hydrolysate on each occasion, to account for variations in preps as well as 
GC/MS analysis. An average value was used for all FSR calculations. 
Calculations 
The fractional synthesis rates (FSR) of mixed, myofibrillar, cytosolic, and 
mitochondrial fractions were calculated using the equation 
EA x [EBW x 3.7 x t (h)]-1 x 100 
where EA represents amount of protein-bound 2H alanine (mole % excess), EBW is the 
quantity of 2H2O in body water (mole % excess), and 3.7 represents the exchange of 2H 
between body water and alanine [i.e. 3.7 of 4 carbon-bound hydrogens of alanine 
exchange with water, (36)]. This equation assumes that 2H-labeling of body water 
equilibrates with free alanine more rapidly than alanine is incorporated into newly made 
protein and that protein synthesis is linear over the study (139).  
In certain circumstances, the intrinsic ability of making proteins (FSR) may not 
accurately reflect differences when accounting for the total amount of proteins being 
made over a unit of time in the entire muscle (total or absolute FSR). Because muscle 
mass and sub-fractional protein contents/concentrations (i.e. protein pools) can differ 
markedly between healthy and diseased individuals, it is possible that one group with a 
reduced muscle mass but elevated FSR will have a lower rate of absolute FSR when 
compared to another group with slower FSR but a larger muscle mass. Previous studies 
 37 
assessing protein turnover in the obese Zucker rat model using in vitro incubation (37), 
flooding dose (106), or 5-6 hours continuous infusion protocols (22, 130) have shown 
that calculated rates of absolute protein synthesis merely exaggerate differences in FSR 
since the obese phenotype exhibits a lower protein mass. However, considering the 
plausibility that the obese phenotype has an increased intrinsic ability of making certain 
proteins (as measured over 24-h with the 2H2O method), but a lower absolute FSR due to 
a reduced protein pool size, we adjusted FSR for sub-fractional protein contents 
(absolute FSR3). Additionally, potential differences in intramyocellular protein 
concentrations, which may affect total enrichment of protein-bound alanine, were 
accounted for by adjusting for sub-fractional protein concentrations (relative FSR4).    
3Absolute FSR: Sub-fractional protein content x (EA x [EBW x 3.7 x t (h)]-1 x 100) 
4Relative FSR:  Sub-fractional protein concentration x (EA x [EBW x 3.7 x t (h)]-1 x 100) 
Isolation of skeletal muscle sub-fractions 
The differential centrifugation protocol for the isolation of subsarcolemmal 
mitochondria and cytosolic proteins was adapted from Rooyackers (108) and 
intermyofibrillar mitochondria and myofibrillar proteins from Wilkinson (136). 
Enrichments of sub fractions were confirmed with Western blotting using cytochrome c 
oxidase IV- [mitochondrial], α-actinin- [myofibrillar], and GAPDH- [cytosolic] specific 
antibodies. A recent study by the Endocrine Research Unit at Mayo Clinic College of 
Medicine reported a 75% purity of the sub-fraction containing subsarcolemmal 
mitochondria with a similar isolation procedure (73). The protocol used to isolate 
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contractile proteins and intermyofibrillar mitochondria has previously been confirmed to 
yield robust enrichments as evidenced by electron microscopy (136). 
Briefly, 100 mg snap-frozen quadriceps/gastrocnemius muscle was thawed and 
gently homogenized with 50 slow and compressive strokes of a glass-pestle (i.e. Dounce 
homogenization technique) in ice-cold mitochondrial isolation buffer 1 (10 mM Hepes, 
200 mM Sucrose, 50 mM Mannitol, 2 mM EDTA disodium salt, Sigma P8340 protease 
inhibitor cocktail, pH 7.4). The homogenate was centrifuged at 600 g for 10 min at 4°C, 
followed by careful removal of the supernatant (cytosolic proteins and subsarcolemmal 
mitochondria [SS]) from the pellet (myofibrillar, nuclear, and stromal proteins, 
intermyofibrillar mitochondria [IMF]). SS mitochondria were obtained by centrifugation 
of the supernatant at 10,000 x g for 10 min (4°C) and were stored in mitochondrial 
isolation buffer 2 (50 mM Hepes, 5 mM EGTA, 1 mM ATP, 100 mM KCl, 5 mM 
MgSO4, Sigma P8340 protease inhibitor cocktail, pH 7.4) until combined with the IMF 
mitochondria for assessment of protein synthesis. The remaining supernatant, containing 
cytosolic proteins, was precipitated with 95% ethanol (50% [v/v] in total solution) 
during low-speed centrifugation at 700 x g for 10 min (4°C) and thereafter dried.  
The pellet produced by the centrifugation of the original homogenate was 
suspended in mitochondrial isolation buffer 3 (100 mM KCl, 50 mM Tris, 5 mM MgCl2 
hexahydrate, 1 mM EDTA disodium salt, 10 mM β-glycerophosphate disodium salt, 50 
mM NaF, 1.5% BSA, Sigma P8340 protease inhibitor cocktail, pH 7.5) and centrifuged 
at 650 x g for 3 min (4°C). The resulting pellet was homogenized in the same buffer with 
a glass pestle using shear and compression to release the intermyofibrillar mitochondria, 
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followed by centrifugation at 650 g for 4 min at 4°C to collect the organelle-rich 
supernatant. IMF mitochondria were then pelleted by centrifugation at 10,000 x g for 10 
min (4°C) and combined with the SS mitochondrial fraction. The mitochondrial-rich 
sub-fractions were washed in isolation buffer 2 and ethanol, followed by high-speed 
centrifugation and drying in preparation for protein synthesis measurements.  
The myofibrillar-rich pellet was washed in mitochondrial isolation buffer 4 
(same as buffer 3 but without BSA) and centrifuged at 1,200 x g for 10 min (4°C) twice, 
which was followed by the addition of 0.3 M NaOH and heating of the sample in a water 
bath for 30 minutes. The myofibrils and collagen were separated by low-speed 
centrifugation at 650 x g for 10 min, and the myofibrillar proteins (supernatant) were 
collected after precipitation with 1 M PCA during low-speed centrifugation, washed 
with ethanol, and dried.  
Muscle protein concentration and content 
Protein concentrations and total protein contents of mixed (i.e. total), 
myofibrillar-, cytosolic-, and mitochondrial-rich sub-fractions were assessed using a 
commercially available colorimetric protein assay and calculated as previously described 
by Frier and Locke (53). Briefly, mitochondrial isolation buffer 1 (250 uL for 
myofibrillar and cytosolic; 50 uL for mitochondria) were added to isolated sub-fractions, 
followed by determination of protein concentration by the BCA method (115). The 
homogenate volumes were multiplied by the concentrations to obtain the total amount of 
protein within each isolated sub-fraction. The resulting values were divided by the mass 
of the homogenized muscle (~75 mg for mitochondrial; ~25 mg for myofibrillar and 
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cytosolic) to yield protein-to-mass ratios (ug/mg wet mass), which were reported as sub-
fractional protein concentrations. Lastly, protein-to-mass ratios were multiplied by the 
mass of the entire quadriceps/gastrocnemius to obtain total protein contents (mg/total 
wet mass).   
Western blotting 
Because muscle harvest was performed 16 h after the last exercise session to 
allow ample time for 2H2O enrichment of slow-turnover proteins (myofibrillar), and the 
window of opportunity to detect changes in Akt-mTOR signaling is ~1-3 h post acute 
RE, the main purpose of this study was to determine basal phenotypical differences in 
total expression of enzymes regulating growth/survival. Thus, if no main effect of RE or 
interaction between phenotype and RE was detected by 2 x 2 ANOVA, data were 
collapsed within phenotypes. Results from sedentary cohorts are presented alongside the 
collapsed data to allow for comparisons of animals in a truly unperturbed state (from an 
acute exercise perspective). Notwithstanding, evaluation of phosphorylation states were 
completed on proteins expected to be activated for many hours post RE, and all groups 
are included in graphs if results were significant.     
Briefly, pulverized mixed gastrocnemius muscle (40 mg) was homogenized in 
400 uL Norris buffer (25 mM Hepes, 5mM β-glycerophosphate, 200µM ATP, 25 mM 
Benzamidine, 2mM PMSF, 4mM EDTA, 10 mM MgCl2, 100 mM NF, 10 mM Na3VO4, 
Sigma protease inhibitor cocktail P8340, 1% TritonX100, pH 7.4). Samples were 
thereafter vortexed at regular intervals in ice-cold conditions for 1 hour and centrifuged 
at 13,000 x g for 30 minutes to separate the cytosolic-rich (supernatant) and the 
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myofibrillar-rich (pellet) protein fractions. The pellets were discarded and a small 
aliquot of each supernatant was used to determine protein concentrations as previously 
described.  
We used the traditional discontinuous Tris-Glycine buffer system developed by 
Ornstein and Davis (28, 100) and further perfected by Laemmli (84) to separate proteins 
using SDS-PAGE. Samples were placed in modified Laemmli buffer (250 mM Tris 
base, 8% SDS, 40% Glycerol, 0.004% Bromophenol Blue, 400 mM DTT) and heated for 
10 minutes at 100°C for denaturation of native proteins into individual subunits.  
Depending upon abundance and molecular weight of the target antigen in rat skeletal 
muscle tissue, 30-100 ug of cytosolic protein were loaded in equal amounts onto 4-15% 
polyacrylamide gels (10 cm x 10 cm x 1.6 mm; 37.5:1 acrylamide/bisacrylamide ratio) 
and subjected to 1 hour electrophoresis in electrode buffer (25 mM Tris base, 19.2 mM 
Glycine, 0.1% SDS, pH 8.3) at 40 mA, holding voltage and power output constant 
(Thermo Scientific Owl P8DS System, Rochester, NY). Each experimental group was 
represented on all gels to minimize confounding effects of gel composition and 
electrophoresis condition.  
Following electrophoresis, filter papers (Munktell Grade 1F) and nitrocellulose 
membranes (~55 cm2, 0.2µm pore size, Amersham Biosciences) were soaked for 10 
minutes in Otter buffer (49.6 mM Tris, 384 mM glycine, 20% methanol [v/v] and 0.01% 
SDS [w/v]) in preparation for semi-dry or wet transfers. Gels were sandwiched between 
wet filter paper, nitrocellulose, and another layer of filter paper, but were not pre-
equilibrated in transfer buffer in order to avoid loss of proteins.  A wet 16-h three-step 
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transfer (Thermo Scientific VEP-2 Mini Tank Electroblotting System, Rochester NY) or 
a or 40-min semi-dry transfer (Thermo Scientific Owl HEP-1 Semi Dry Electroblotting 
System, Rochester, NY) was used to transfer proteins onto the membranes. A 
progressive three-step wet transfer, consisting of 1 h at 1.3 mA/cm2, 14 h at 3.8 mA/cm2, 
and lastly 1 hr at 7.5 mA/cm2, maximizes chances of eluting high-molecular weight 
proteins from the gel while maintaining binding of low molecular weight proteins to the 
membrane. Although a 40-min semi-dry transfer at 400 mA (~7.5 mA/cm2) was 
sufficient for most molecular weight proteins, elution efficiency of proteins such as 
mTOR (289 kD) and raptor (150 kD) were significantly improved with the wet method. 
Loading consistency and transfer efficiency were verified with Ponceau S stain (0.1% 
Ponceau S [w/v], 5% acetic acid [v/v]) of the membranes and Coomassie blue staining 
(50% trichloroacetic acid [w/v], 0.1% Coomassie Brilliant Blue [w/v]) followed by 
destaining (50% methanol [v/v], 10% acetic acid [v/v]) of the gels.  
Membranes were blocked for 1 hour in blocking buffer (20 mM Tris base, 5% 
dry milk [w/v], 8% NaCl [w/v], 100 mM NF, 10 mM Na3VO4 ), and thereafter incubated 
overnight at 4°C under gentle agitation in a heat-sealed plastic bag containing 1:1000 
primary antibody/blocking buffer. Following a 15 min (3 x 5 min) wash-step in wash 
buffer (20 mM Tris base, 8% NaCl [w/v], 100 mM NF, 10 mM Na3VO4),  membranes 
were incubated for 1 hour at room temperature with a 1:2000 secondary 
antibody/blocking buffer solution under continual agitation. After repeating the 15 min 
wash-step, membranes were incubated for 5 minutes in 10 mL of enhanced 
chemiluminescent substrate (ECL; 50% [v/v] Pierce Super Signal West Pico Luminol 
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Enhancer Solution, 50% [v/v] Super Signal West Pico Stable Peroxidase Solution) and 
protein bands were developed with a CCD camera, mounted in a FluorChem SP imaging 
system (Alpha Innotech, San Leandro, CA). Optical density was determined using 
AlphaEase FC software (Alpha Innotech), which was automatically set to subtract non-
specific binding from densitometry values. All bands were analyzed three times and the 
average density values were normalized between membranes and expressed as arbitrary 
units. Expression of proteins regulating growth/survival and mRNA translation 
initiation/elongation were of prime interest and membranes were probed for protein 
kinase B (PKB; Akt), mammalian target of rapamycin (mTOR), regulatory associated 
protein of mTOR (Raptor), regulated in development and DNA damage responses 1 
(REDD1), proline-rich Akt substrate (PRAS40), p70 ribosomal S6 kinase (p70s6k), 
phospho-p70s6k [threonine 389], eukaryotic initiation factor 4E binding protein 1 
(eIF4EBP1), phospho-eIF4EBP [threonine 37/46], eukaryotic elongation factor 2 
(eEF2), phospho-eEF2 [threonine 56], eEF2K, extracellular signal-regulated kinases 1 
and 2 (ERK1/ERK2; P44/P42), eukaryotic initiation factor 2B epsilon (eIF2Bε), and 
atrogin-1/MAFbx. Immunodetection of phosphorylated antigens were completed before 
assessment of total protein. Membranes were stripped for 15 minutes at room-
temperature (Restore Western Blot Stripping Buffer, Thermo Scientific) and reincubated 
with ECL to ensure no residual chemiluminescence. All primary (rabbit and mouse) and 
secondary antibodies (anti-rabbit and anti-mouse) were purchased from Cell Signaling 
(Beverly, MA, USA) except atrogin-1 (ECM Biosciences, Versailles, KY) and eIF2Bε, a 
kind gift from Scot Kimball, Pennsylvania State University. 
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Immunoprecipitation 
Complexation of eIF4EBP1 and eIF4G with eIF4E in gastrocnemius muscle was 
measured using a standard immunoprecipitation technique based on the high binding 
affinity of bacterial membrane proteins A/G to immunoglobulins. Briefly, 100 µg 
cytosolic proteins in modified Norris buffer [total volume of ~70µL] (0.3% Chaps, 1 
mM DTT, 25 mM Hepes, 5mM β-glycerophosphate, 200µM ATP, 25 mM Benzamidine, 
2mM PMSF, 4mM EDTA, 10 mM MgCl2, 100 mM NF, 10 mM Na3VO4, Sigma 
protease inhibitor cocktail P8340, pH 7.4) were gently agitated overnight at 4°C with 1 
µL rabbit monoclonal eIF4E antibody (1:70 ratio; Cell Signaling). Collection of 
antigen/antibody complexes was achieved by adding 20 µL 50% protein A agarose bead 
slurry to each sample followed by 3-h incubation at 4°C.  Samples were then centrifuged 
at 10,000 x g for 1 min at 4°C and pellets resuspended in 500 µL Norris buffer for a total 
of three times to remove unbound antibodies. The final pellet was denatured in 20 µL 4X 
Laemmli buffer (250 mM Tris base, 8% SDS, 40% Glycerol, 0.004% Bromophenol 
Blue, 400 mM DTT) by heating at 95°C for 10 minutes and thereafter centrifuged at 
10,000 x g for 1 min. The resulting supernatant was subjected to electrophoresis using a 
7.5% (eIF4G) and 15% (eIF4EBP1) polyacrylamide gel followed by semidry transfer to 
nitrocellulose membranes as previously described. The blots were then gently agitated 
overnight at 4°C with mouse monoclonal eIF4E (Santa Cruz Biotechnology, CA, USA), 
mouse monoclonal eIF4EBP (Santa Cruz), and rabbit polyclonal eIF4G (Cell Signaling) 
at a 1:200-1:1000 ratio. Lastly, membranes were incubated with anti-rabbit or anti-
 45 
mouse secondary antibodies (1:2000 ratio; Cell Signaling) for 1 hour at room 
temperature and developed with ECL.                      
Statistical analyses 
The effects of phenotype (obese vs. lean) and physical activity (sedentary vs. 
resistance exercise [RE]) on expression and synthesis of proteins were assessed with 2 x 
2 ANOVA using SigmaStat version 3.5. When significant F-ratios were present, a 
Student-Newman-Keuls post hoc procedure was used to evaluate differences among 
group means. If there was no main effect of RE or interaction between RE and 
phenotype using 2-way analysis of variance, Western blotting data were collapsed within 
phenotypes (Fat [F; n = 14 and Lean [L; n = 16]). To allow for comparisons of animals 
in truly unperturbed states (from an acute exercise perspective), differences between 
sedentary cohorts (FS vs. LS) were assessed for significance with independent t-tests and 
presented as inserts in the graphs depicting the collapsed data (for further rationale see 
methods). If homogeneity of data failed, analyses of variance were conducted on 
transformed values (square-root) and statistical comparisons between two independent 
group means were completed with Mann-Whitney-Wilcoxon rank sum tests. 
Significance was set at P ≤ 0.05 and all data are presented as means ± SE.   
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Results 
Wet mass, protein content, and protein concentration  
As expected, quadriceps and gastrocnemius wet mass and total protein content, 
but not protein concentration, were significantly suppressed in the obese phenotype (P < 
0.05), and acute resistance exercise (RE) did not significantly affect muscle weights or 
protein contents/concentrations in either cohort (Figs. 5-6). The ~22% difference in 
mixed protein content of gastrocnemius muscle between phenotypes (P < 0.001) was 
primarily attributed to ~25% lower myofibrillar protein content (P < 0.001; 176 ± 9 mg 
and 236 ± 9 mg in obese vs. lean rats, respectively) and secondarily ~15% lower 
cytosolic protein content (P = 0.04; 77 ± 5 mg and 91 ± 5 mg in obese vs. lean rats, 
respectively) in obese rats. Similarly, the ~35% difference in mixed protein content of 
quadriceps muscle between phenotypes (P < 0.001) was attributed to ~36% lower 
myofibrillar protein content (P < 0.05; 296 ± 44 mg and 461 ± 55 mg in obese vs. lean, 
respectively), ~35% lower cytosolic protein content (P < 0.001; 109 ± 11 mg and 167 ± 
6 mg in obese vs. lean, respectively), and ~28% lower mitochondrial protein content (P 
= 0.021; 5.7 ± 0.41 mg and 7.9 ± 0.77 mg in obese vs. lean) in obese rats. Although total 
mitochondrial content was significantly suppressed in quadriceps muscle of obese rats, 
mitochondrial density/concentration was not significantly different between phenotypes 
(P = 0.635; 3.41 ± 0.22 µg/mg and 3.15 ± 0.36 µg/mg in obese vs. lean, respectively). 
The most interesting and novel finding in this study in regards to muscle composition 
was that total mitochondrial protein content in gastrocnemius muscle was not 
significantly different between phenotypes (2.73 ± 0.23 mg and 2.57 ± 0.23 mg in obese 
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vs. lean, respectively) due to a ~31% higher mitochondrial density/concentration in 
obese rats (P = 0.01; 1.86 ± µg/mg and 1.42 ± µg/mg in obese vs. lean, respectively). 
From a biological standpoint it makes sense that the obese phenotype, which exhibits a 
higher amount of  intramuscular lipids due to an upregulation of plasmalemmal and 
mitochondrial FAT/CD36 in gastrocnemius muscle (69), has more mitochondria per unit 
muscle in order to handle an increased lipid load (6, 69). Wet weights of solues and 
plantaris were significantly suppressed in obese vs. lean rats (P ≤ 0.001), but no 
significant differences were found between experimental conditions within phenotypes 
(Table 1).      
In agreement with previous research, we show no differences in total protein 
concentration between phenotypes (37) and a significantly lower total protein content in 
obese rats (113). The relative contributions of myofibrillar (~55-65%), stromal (~10-
15%), and cytosolic fractions (~20-30%) to the mixed protein pool compare well with 
what has been published previously in this model (87). Mitochondrial content generally 
ranges from 1 to 3% of total cellular volume (70) and corresponding values obtained in 
our study are at the lower end of this spectrum.  
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Fig. 5. Wet mass (Panel A), protein contents (Panel B), and protein concentrations (Panel C) of mixed gastrocnemius muscle. Panel A: Average wet mass of left and right 
gastrocnemius muscle. Main effect of phenotype (P < 0.001; 1.81 ± 0.03 g vs. 1.44 ± 0.03 g in lean vs. obese rats, respectively). Panel B: Mixed (total value), myofibrillar (bottom 
dark gray stack), sarcoplasmic (middle light gray stack), and mitochondrial (top white stack) protein contents. Main effect of phenotype on mixed (P ≤ 0.001), myofibrillar (P ≤ 
0.001), and sarcoplasmic (P = 0.04) protein contents, but not mitochondrial (P = 0.556). Panel C: Mixed (total), myofibrillar (bottom), sarcoplasmic (middle), and mitochondrial 
(top) protein concentrations. Main effect of phenotype on mitochondrial protein concentrations (P = 0.01), but not mixed (P = 0.417), myofibrillar (0.194), or sarcoplasmic (0.552). 
As expected, two-way analyses of variance indicated no main effect of RE or interaction between RE and phenotype on any of the aforementioned outcome variables. Values 
(means ± standard error [SE]) are expressed in grams (g; Panel A), milligrams/total wet mass (mg; Panel B), micrograms/milligrams wet mass (µg/mg; Panel C), and relative to 
total protein contents/concentrations (%, within bars). Letters superscripted within bars denote significance in absolute values between experimental conditions according to SNK 
post hoc analysis or t-test (P ≤ 0.05 if groups do not share the same letter).    
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Fig. 6. Wet mass (Panel A), protein contents (Panel B), and protein concentrations (Panel C) of mixed quadriceps muscle. Panel A: Average wet mass of left and right 
quadriceps muscle. Main effect of phenotype (P < 0.001; 2.61 ± 0.08 g vs. 1.69 ± 0.07 g in lean vs. obese rats, respectively). Panel B: Mixed (total value), myofibrillar (bottom 
dark gray stack), sarcoplasmic (middle light gray stack), and mitochondrial (top white stack) protein contents. Main effect of phenotype on mixed (P = 0.007), myofibrillar (P = 
0.048), mitochondrial (P = 0.021), and sarcoplasmic (P < 0.001) protein contents. Panel C: Mixed (total), myofibrillar (bottom), sarcoplasmic (middle), and mitochondrial (top) 
protein concentrations. No main effect of phenotype on mitochondrial (P = 0.635), mixed (P = 0.643), myofibrillar (0.982), or sarcoplasmic (0.989) protein concentrations. Two-
way analyses of variance indicated no main effect of RE or interaction between RE and phenotype on any of the aforementioned outcome variables. Values (means ± standard 
error [SE]) are expressed in grams (g; Panel A), milligrams/total wet mass (mg; Panel B), micrograms/milligrams wet mass (µg/mg; Panel C), and relative to total protein 
contents/concentrations (%, within bars). Letters superscripted within bars denote significance in absolute values between experimental conditions according to SNK post hoc 
analysis or t-test (P ≤ 0.05 if groups do not share the same letter). *Denotes borderline significant: Myofibrillar protein content, LE vs. FE (P = 0.063); mitochondrial protein 
content, LE vs. FS (P = 0.076).    
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Table 1. Wet mass of soleus and plantaris  
 
 
 
Cumulative fractional rates of protein synthesis (FSR) 
We used heavy water (deuterium oxide, 2H2O) to assess 24-h cumulative 
synthesis rates of mixed, mitochondrial (mito), cytosolic (cyto), and myofibrillar (myo) 
proteins in skeletal muscle of sedentary and resistance exercised lean and obese Zucker 
rats. Considering that uncertainties still exist regarding relative turnover rates of skeletal 
muscle sub-fractions, primarily attributed to considerable methodological variations 
between studies, comparisons between myocellular compartments should be viewed 
cautiously. In this study, the average synthesis rates of mixed (3.41%/d and 4.57%/d), 
myofibrillar (2.48%/d and 2.81%/d), and cytosolic (8.93%/d and 6.49%/d) sub-fractions 
in quadriceps and gastrocnemius muscle, respectively, are qualitatively similar to 
previous observations in humans and rats (i.e. Myo FSR < Mixed FSR < Cyto FSR). An 
approximate two- to three-fold difference between cytosolic and myofibrillar protein 
synthesis rates is viewed as normal in the postabsorptive state, and mixed FSR is 
typically 30-40% higher compared to myofibrillar FSR. In our hands, the average 
 
                                           FS                              FE                             LS                           LE                    Phenotype      Activity           P*A 
 
Wet Mass (g) 
 
Soleus  
 
 
 
0.183 ± 0.009ac 
 
 
 
 
0.174 ± 0.009a 
 
 
 
 
0.216 ± 0.007b 
 
 
 
 
0.198 ± 0.007bc 
 
 
 
 
P = 0.001 
 
 
 
P = 0.108 
 
 
 
P = 0.597 
 
Plantaris 
 
 
  0.275 ± 0.02a 
 
 
  0.279 ± 0.01a 
 
 
  0.387 ± 0.01b 
 
 
  0.364 ± 0.02b 
 
 
P < 0.001 
 
P = 0.548 
 
P = 0.359 
        
Table 1. Wet mass of soleus and plantaris 
 
Values are means ± SE and expressed in grams (g). 2 x 2 ANOVA main effects (Phenotype, Activity) and interactions (P x A) are 
included to the far right in the table. Groups not sharing the same letter are significantly different as evaluated by SNK post hoc or 
t-tests (P ≤ 0.05).   
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synthesis rate of the two pools of mitochondria is ~5-15% higher compared to the mixed 
protein pool (4.00%/d vs. 3.41%/d and 4.76%/d vs. 4.57%/d) in quadriceps and 
gastrocnemius muscle, respectively.  
Distal muscle groups (gastrocnemius, soleus, and plantaris) 
We found that the obese phenotype exhibited a mild, but significant, suppression 
of 24-h protein synthesis rates in mixed and myofibrillar sub-fractions (-11%, P = 0.015; 
-12%, P = 0.007, respectively) of gastrocnemius muscle, while cytosolic and 
mitochondrial FSR were not different from lean rats (Fig. 7A; 8A,C,E). In lieu of the fact 
that there was no statistical difference in mixed FSR between sedentary groups (P = 
0.437; FS vs. LS), the observed phenotypical suppression was partly attributed to a 
modest exercise effect in the lean phenotype (P = 0.165; 4.62 ± 0.22 %/d and 5.00 ± 0.18 
%/d in LS vs. LE, respectively). Myofibrillar FSR was significantly lower in obese vs. 
lean rats (2.64 ± 0.06 %/d and 2.99 ± 0.10 %/d in obese vs. lean rats, respectively), but 
there were no differences in this sub-fraction between exercised and sedentary cohorts. 
Similarly, mitochondrial FSR was not statistically different between exercised vs. 
sedentary obese rats (P = 0.349; 4.23 ± 0.28 %/d and 4.72 ± 0.34 %/d in FS vs. FE, 
respectively), but the 12% higher synthesis rate in the FE cohort indicates a mild 
exercise effect on this organelle in the obese phenotype. In contrast to obese rats, 
mitochondrial FSR was significantly higher in exercised vs. sedentary lean rats (+20%, P 
= 0.049; 4.41 ± 0.44 %/d and 5.54 ± 0.39 %/d in LS vs. LE, respectively), suggesting an 
increased mitochondrial sensitivity to contractile stimuli compared to the obese 
phenotype. Despite a blunted anabolic response to exercise in obese rats, there was no 
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significant difference in the ability of making mitochondrial proteins between 
phenotypes in the sedentary state (P = 0.738). Synthesis rates of mixed proteins in 
soleus, but not plantaris, were significantly lower in obese vs. lean rats (-7%, P = 0.044, 
Table 2), but sub-fractional synthesis rates were not explored in these muscle groups due 
to tissue quantity necessary for fractionation. Considering that there was no statistical 
difference between sedentary cohorts in lean vs. obese rats (P > 0.05), the observed main 
effect of phenotype was partially attributed to a modest exercise effect in lean rats (+6%, 
LE vs. LS). Our finding that FSR may be preferentially suppressed in predominately 
slow/red muscles over fast/white muscles supports previous findings by Fluckey and 
colleagues  who reported a significantly lower FSR in red but not white gastrocnemius 
muscle in this rats strain (47).  
As expected, when analyzing rate at which proteins were made in each sub-
fraction on a whole muscle level (Fig. 7B; Fig. 8B,D,F), absolute FSR of mixed and 
myofibrillar proteins were significantly lower in the obese phenotype (-30%, P < 0.001; -
34%, P < 0.001). However, when cytosolic and mitochondrial FSR were adjusted for 
total protein content (Fig. 8DF) and protein concentration (Fig. 8DF, inserts), no 
significant differences were detected between phenotypes. As a matter of fact, 
mitochondrial FSR adjusted to protein concentration was ~20% higher in obese vs. lean 
rats, but this did not reach statistical significance (P = 0.269). Because the intrinsic 
ability of synthesizing mitochondrial proteins was similar between phenotypes, a 
significantly higher mitochondrial protein concentration solely accounted for the 
elevated adjusted FSR in obese rats.  
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Fig. 7. Mixed protein synthesis rates of gastrocnemius muscle. Panel A: Intrinsic capacity of synthesizing mixed proteins (FSR) over a 24-h period. Main effect of phenotype 
(P = 0.015); FE vs. LE, P = 0.006; FE vs. LS, P = 0.153; FS vs. LE, P = 0.049; LS vs. LE, P = 0.165. Panel B: Protein synthesis over a 24-h period adjusted for mixed protein 
content (Absolute FSR). Main effect of phenotype (P < 0.001); FS vs. LS, P = 0.022; FS vs. LE, P = 0.011; FE vs. LS, P = 0.006; FE vs. LE, P < 0.001. Insert: 24-h FSR 
adjusted for mixed protein concentration. Main effect of phenotype (P = 0.042); FS vs. LE, P = 0.126; FE vs. LS, P = 0.197; FE vs. LE, P = 0.025. Two-way analyses of 
variance indicated no main effect of RE or interaction between RE and phenotype on any of the aforementioned outcome variables. Bars/groups sharing the same letter are not 
significantly different (P > 0.05) according to SNK post hoc analyses or t-tests. Data are expressed as %/d, with or without adjustments for protein content and protein 
concentration, and presented as means ± standard error (SE).    
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Fig. 8.  Sub-fractional protein synthesis rates of gastrocnemius muscle. Panel A: MYO FSR. Main effect of phenotype (P = 
0.007); FS vs. LS, P = 0.035; FS vs. LE, P = 0.008; FE vs. LS, P = 0.130, FE vs. LE, P = 0.072. Panel B:  Absolute MYO 
FSR. Main effect of phenotype (P < 0.001); FS vs. LS, P = 0.004; FS vs. LE, P = 0.008; FE vs. LS, P = 0.005, FE vs. LE, P 
< 0.001. Insert: 24-h FSR adjusted for MYO protein concentration. Main effect of phenotype (P = 0.018); FS vs. LS, P = 
0.156; FS vs. LE, P = 0.137; FE vs. LS, P = 0.066, FE vs. LE, P = 0.042. Panel C-D:  Two-way ANOVA indicated no 
significant effects of phenotype, RE, or interactions (RE x phenotype) on CYTO outcome variables. Panel E: MITO FSR. 
Main effect of resistance exercise (P = 0.042) but not phenotype (P = 0.19); FS vs. FE, P = 0.349; FS vs. LE, P = 0.028; FE 
vs. LE, P = 0.111; LS vs. LE, P = 0.042. Panel F: No effects of phenotype or RE on adjusted MITO FSR. Bars/groups 
sharing the same letter are not significantly different (P > 0.05) according to SNK post hoc analyses or t-tests. Data are 
expressed as %/d, with or without adjustments for protein content and protein concentration, and presented as means ± 
standard error (SE). 
 
Table 2. Fractional protein synthesis rates (FSR) of soleus and plantaris 
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Table 2. Fractional protein synthesis rates (FSR) of soleus and plantaris 
 
 
Proximal muscle groups (quadriceps) 
In contrast to gastrocnemius and soleus, 24-h protein synthesis rates of mixed 
proteins in quadriceps muscle were significantly higher in obese vs. lean rats (+14%, P = 
0.007, Fig. 9A), which in part was due to a mildly elevated FSR in the cytosolic fraction 
of the obese phenotype (+8%, P = 0.221, Fig. 10C). No significant differences were 
found between phenotypes in the intrinsic capacity to synthesize myofibrillar (P = 0.517, 
Fig. 10A) or mitochondrial proteins (P = 0.996, Fig. 10E). Myofibrillar (P = 0.062; 2.14 
± 0.14 %/d and 2.98 ± 0.42 %/d in LS vs. LE, respectively) and cytosolic (P = 0.042; 
7.95 ± 0.51 %/d and 9.32 ± 0.55 %/d in LS vs. LE, respectively) FSR were 40% and 
17% higher, respectively, in exercised vs. sedentary lean rats.  
 
 
 
 
                                           FS                           FE                              LS                               LE                     Phenotype        Activity           P*A 
 
FSR (%/d) 
 
Soleus 
 
 
Plantaris                                                                                                                                            
 
 
 
6.38 ± 0.16ab 
 
 
4.72 ± 0.39 
 
 
 
6.23 ± 0.23a 
 
 
4.42 ± 0.25
 
 
 
6.62 ± 0.14ab 
 
 
4.97 ± 0.52
 
 
 
7.00 ± 0.34b 
 
 
4.75 ± 0.54 
 
 
 
 
P = 0.044 
 
 
P = 0.505 
 
 
 
P = 0.635 
 
 
P = 0.573 
 
 
 
P = 0.281 
 
 
P = 0.916 
 
        
       
Values are means ± SE and expressed as percent per hour (%/h). 2 x 2 ANOVA main effects (Phenotype, Activity) and 
interactions (P x A) are included to the far right in the table. Groups not sharing the same letter are significantly different as 
evaluated by SNK post hoc or t-tests (P ≤ 0.05).   
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The exercise response was blunted in the obese phenotype with non-significantly 
higher myofibrillar (P = 0.667; 2.31 ± 0.23 %/d and 2.46 ± 0.25 %/d in FS vs. FE, 
respectively) and cytosolic (P = 0.366; 8.90 ± 0.47 %/d and 9.55 ± 0.55 %/d in FS vs. 
FE, respectively) FSR in exercised vs. sedentary obese rats. Interestingly, a diminished 
exercise response in obese rats may in part be due to an elevated basal state, at least in 
the cytosolic sub-fraction, as exercise levels were similar between phenotypes.     
When analyzing the rate of proteins made in each sub-fraction on a whole muscle 
level, absolute FSR of mixed, myofibrillar, cytosolic, and mitochondrial proteins in 
quadriceps were significantly suppressed in the obese phenotype (P < 0.05; Fig. 9B; Fig. 
10B,D,F). No significant differences were detected between phenotypes or experimental 
conditions when FSR was adjusted for mixed (Fig. 9B, insert) or sub-fractional protein 
concentrations (Fig. 10B,D,F, inserts). Similar to gastrocnemius muscle, mitochondrial 
FSR adjusted to protein concentration was elevated ~16% in quadriceps of obese vs. lean 
rats, but this did not reach statistical significance (P = 0.29).  
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Fig. 9. Mixed protein synthesis rates of quadriceps muscle. Panel A: Intrinsic capacity of synthesizing mixed proteins (FSR) over a 24-h period. Main effect of phenotype (P = 0.007); FS 
vs. LS, P = 0.019; FS vs. LE, P = 0.133; FE vs. LS, P = 0.014; FE vs. LE, P = 0.112. Panel B: Protein synthesis over a 24-h period adjusted for mixed protein content (Absolute FSR). Main 
effect of phenotype (P = 0.02); FS vs. LS, P = 0.176; FS vs. LE, P = 0.132; FE vs. LS, P = 0.056; FE vs. LE, P = 0.038. Insert: 24-h FSR adjusted for mixed protein concentration. No main 
effect of phenotype (P = 0.462). Two-way analyses of variance indicated no main effect of RE or interaction between RE and phenotype on any of the aforementioned outcome variables. 
Bars/groups sharing the same letter are not significantly different (P > 0.05) according to SNK post hoc analyses or t-tests. Data are expressed as %/d, with or without adjustments for 
protein content and protein concentration, and presented as means ± standard error (SE).    
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Fig. 10.  Sub-fractional protein synthesis rates of quadriceps muscle. Panel A: MYO FSR. Borderline main effect of RE (P = 
0.081); LS vs. LE, P = 0.062. Panel B:  Absolute MYO FSR. Main effect of phenotype (P = 0.034) and borderline main effect 
of RE (P = 0.11); FS vs. LE, P = 0.043; FE vs. LE, P = 0.05; LS vs. LE, P = 0.129. Insert: 24-h FSR adjusted for MYO protein 
concentration. Two-way ANOVA indicated no effects of phenotype (P = 0.856), RE (P = 0.196), or interaction (RE x 
phenotype; P = 0.791). Panel C: CYTO FSR. Main effect of RE (P = 0.042); LS vs. LE, P = 0.037; FE vs. LS, P = 0.052. Panel 
D: Absolute CYTO FSR. Main effect of phenotype (P = 0.007); FS vs. LS, P = 0.023; FS vs. LE, P = 0.01; FE vs. LS, P = 
0.065; FE vs. LE, P = 0.1. Insert: 24-h FSR adjusted for CYTO protein concentration. Two-way ANOVA indicated no 
significant effects of phenotype (P = 0.606), RE (P = 0.27), or interaction (RE x phenotype; P = 0.332).  Panel E: MITO FSR. 
No significant effects of phenotype, RE, or interaction. Panel F: Absolute MITO FSR. Main effect of phenotype (P = 0.037); 
FS vs. LS, P = 0.043; FS vs. LE, P = 0.147; FE vs. LS, P = 0.105. Insert: 24-h FSR adjusted for MITO protein concentration. 
No significant effects of phenotype, RE, or interaction.  Bars/groups sharing the same letter are not significantly different (P > 
0.05) according to SNK post hoc analyses or t-tests. *Denotes borderline different (see text caption). Data are expressed as 
%/d, with or without adjustments for protein content and protein concentration, and presented as means ± standard error (SE). 
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Expression and regulation of growth/survival signals (Akt-mTOR pathway) 
Considering that acute RE is less likely to induce permanent adaptations in 
skeletal muscle compared to resistance training, and that muscle harvest occurred 16 
hours after the last exercise session, we did not expect major differences in expression or 
activity of anabolic signals between sedentary and resistance-exercised groups. As 
anticipated, we did not find a higher expression/activity of the typical regulators of 
protein synthesis [Akt-mTOR- p70s6k] in gastrocnemius muscle when assessed 16 hours 
post RE (Fig. 11A-C; collapsed data), despite elevated 24-h mixed and mitochondrial 
FSR in the exercised lean cohort. The most notable exception was a more robust 
phosphorylation of eIF4EBP1 in obese (+ 54%) and lean (+17%) RE groups compared 
to sedentary controls (Fig. 12B), but no statistical differences in eIF4E·eIF4EBP1 or 
eIF4E·eIF4G association between experimental conditions were found (Fig. 13). As a 
result, Western blotting data from sedentary and exercised groups were collapsed within 
each phenotype (Fatty [F] vs. Lean [L]) unless there was a main effect of RE or 
interaction between phenotype and RE. 
 Obese rats exhibited a lower expression of key anabolic proteins including Akt 
(-16%, P = 0.074), mTOR (-26%, P = 0.058), and Raptor (-24%, P = 0.013), but no 
differences in P44/P42, eIF2Bε, and eIF2α were detected (Fig. 11A-F). Despite a lower 
cytosolic abundance of these important upstream mediators of muscle growth, the 
activation of downstream targets regulating mRNA translation initiation were not 
compromised compared to lean rats, as evidenced by a more robust phosphorylation of 
mTOR substrates eIF4EBP1(+28%, Fig. 12B), the major binding protein regulating 
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eIF4E activity and 5‟cap-dependent translation, and p70s6k (+162%, Fig. 14B), the main 
enzyme responsible for phosphorylating the S6 protein in the 40S ribosomal subunit. A 
tendency for a decreased association between eIF4E and eIF4EBP1 was noted in the 
obese phenotype (-28%, obese vs. lean), but this did not reach statistical significance (P 
= 0.417, Fig. 13). In lieu of the fact that we observed a more robust phosphorylation of 
down-stream initiators of mRNA translation, we decided to measure the 
abundance/activity of key regulatory proteins in peptide-chain elongation in an attempt 
to explain the observed suppression in mixed and myofibrillar protein synthesis rates in 
the obese phenotype. Collapsed data did not indicate a lower expression of eukaryotic 
elongation factor 2 (eEF2) or a more potent inhibition of eEF2 (Thr 56) in obese vs. lean 
rats (Fig. 15A-D). However, when sedentary groups were analyzed separately, we found 
that the obese phenotype exhibited a stronger deactivation of peptide-chain elongation 
compared to lean rats, as evidenced by 87% higher phospho/total ratio of eEF2 (Fig. 
15C, insert). We did not detect any significant phenotypical differences in expression of 
eEF2-inihibitory factor eEF2K or the negative mTOR regulators PRAS40 and REDD1 
(Fig. 16A-C). Albeit not directly affecting protein synthesis per se, atrogin-1 (E3 ligase 
of the ubiquitin-proteasome proteolytic pathway) expression was significantly higher in 
the sedentary obese group compared to its lean counterpart (Fig. 16D, insert), indicating 
that other mechanisms, such as protein degradation, may contribute to the skeletal 
muscle atrophy observed in the obese phenotype.    
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Fig. 11. Expression of proteins regulating growth in gastrocemius muscle. If no main effect of RE or interaction between RE 
and phenotype were detected by 2-way ANOVA, data were collapsed within each phenotype and presented as Fatty (F) vs. 
Lean (L). The sedentary conditions represent unperturbed states from an exercise standpoint and are included as inserts. 
Panel A-C: The obese phenotype exhibited borderline lower Akt and mTOR expression (P = 0.077 and P =0.058, 
respectively), and significantly lower Raptor expression (F vs. L, P = 0.013; FS vs. LS, P =0.006) compared to its lean 
counterpart. No differences were detected in expression of proteins considered to be independent of traditional mTOR 
signaling, including ERK1/ERK2 (Panel D), eIF2Bε (Panel E), and eIF2α (Panel F). Optical density values are means ± SE 
and expressed in arbitrary units. Groups that do not share the same letter are significantly different (P ≤ 0.05) as evaluated 
by two-way ANOVA (F vs. L, main effect of phenotype), SNK post analyses (FS vs. LS, Raptor expression), or 
independent t-tests (all other comparisons). * Denotes borderline difference between phenotypes (see text caption).   
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Fig. 12. Expression of total, phospho-specific, and phospho/total ratio eIF4EBP1 in gastrocnemius muscle. The number of animals used for each blot is indicated in the table along with 
2 x 2 ANOVA main effects (Phenotype, Activity) and interactions (P x A) (Panel D). A representative blot of each experimental condition is included below the table. Optical density 
values are means ± SE and expressed in arbitrary units. Groups not sharing the same letter are significantly different as evaluated by SNK post hoc or t-tests (P ≤ 0.05).    
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Fig. 13. Association of eIF4EBP1 (Panel A) and eIF4G (Panel B) with eIF4E in gastrocnemius muscle. 
Immunoprecipitation (IP) of eIF4E was followed by electrophoresis and quantification of amount of eIF4EBP1 and 
eIF4G bound to eIF4E by immunoblotting (IB). A representative Western blot is included above the figures (n = 4 in each 
group). Optical density values are means ± SE and expressed in arbitrary units. No significant differences were found 
between groups (P > 0.05).   
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Fig. 14. Expression of total, phospho-specific, and phospho/total ratio p70s6k in gastrocnemius muscle. The number of animals used for each blot is indicated in the table along 
with significance values obtained from 2 x 2 ANOVA [F vs. L, main effect of phenotype] (Panel D). A representative blot of each experimental condition is included below the 
table. Optical density values are means ± SE and expressed in arbitrary units. Groups not sharing the same letter are significantly different (P ≤ 0.05).     
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Fig. 15. Expression of total, phospho-specific, and phospho/total ratio of eEF2 in gastrocnemius muscle. The number of animals used for each blot is indicated in the table along with 
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Fig. 16. Expression of inhibitors of growth in gastrocnemius muscle. If no main effect of RE or interaction between RE 
and phenotype were detected by 2-way ANOVA, data were collapsed within each phenotype and presented as Fatty (F) 
vs. Lean (L). No phenotypical differences were detected in expression of proteins inhibiting mTOR signaling, including 
PRAS40 (Panel A) and REDD1 (Panel B). Basal expression of AMPK-activated eFE2K, an inhibitor of eukaryotic 
elongation factor 2, was borderline different between sedentary groups (P = 0.133). Although not directly involved in 
protein synthesis, atrogin-1 expression was significantly elevated in sedentary obese rats (P = 0.029). Optical density 
values are means ± SE and expressed in arbitrary units. Groups that do not share the same letter are significantly different 
(P ≤ 0.05) as evaluated by independent t-tests.  
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Discussion 
The primary aim of this study was to determine if insulin resistance alters the 
adaptive response of sub-cellular compartments regulating substrate metabolism and 
energy utilization in skeletal muscle following contractile activity. To achieve this goal, 
we employed a well-established resistance exercise (RE) model in diabetic rats (44) in 
conjunction with a novel precursor-product labeling technique that centers on the use of 
heavy water (deuterium oxide, 2H2O) to measure protein turnover. The attractiveness of 
2H2O as a metabolic label lies in its proven utility for assessing long-term biosynthesis of 
macromolecules in a variety of species under free-living conditions (18), including obese 
rodent models (3). We extended previous research by measuring 24-h (cumulative) 
protein synthesis rates of mixed, mitochondrial, cytosolic, and myofibrillar sub-fractions 
in skeletal muscle of lean and obese Zucker rats following resistance exercise. To our 
knowledge, the current study is the first to address whether or not insulin resistance 
alters the cumulative anabolic response to voluntary resistance exercise in sub-fractions 
of skeletal muscle.  
Insulin resistance is typically associated with mitochondrial dysfunction and the 
current RE paradigm was designed to promote muscular endurance as well as protein 
anabolism (see methods). We were partially successful in achieving this goal since 
mitochondrial FSR in gastrocnemius was significantly augmented in the lean phenotype 
(+20%), which was accompanied by a modest increase in cytosolic and mixed protein 
synthesis rates (+6% and +8%, respectively), but no change in myofibrillar FSR (-0.4%). 
We did, however, observe a robust amplification of myofibrillar and cytosolic synthesis 
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rates in quadriceps muscle of lean rats (+40% and +17%, respectively), which strongly 
suggests that our RE protocol indeed was anabolic. Interestingly, the exercise-induced 
anabolic response was altered in gastrocnemius of the obese phenotype, but this was 
primarily due to a blunted increase in mitochondrial FSR (+12%), with no significant 
changes in cytosolic, myofibrillar, or mixed FSR (-1%, + 3%, -4%, respectively). These 
results suggest that there is a fraction-specific resistance to contractile stimuli in this 
muscle group. In addition, obese rats were unable to augment synthesis rates of 
myofibrillar and cytosolic proteins in quadriceps to the same extent as lean rats, further 
supporting the notion of a reduced sensitivity to contractile activity-induced stimuli in 
the insulin-resistant state. These findings are partly supported by studies that have 
utilized compensatory loading models, insulin, or nutrients to promote protein synthesis 
in insulin-resistant humans and rodent models, although diverging results exist (9, 50, 
59, 60, 94, 102, 121). Muscle growth was recently shown to be blunted in soleus muscle 
(84% SO fibers) of obese Zucker rats following synergistic ablation of gastrocnemius 
and plantaris (59). In contrast, a near identical hypertrophic response was demonstrated 
in plantaris muscle (94% FG/FOG fibers) of obese rats compared to their lean 
counterparts following synergistic denervation of soleus and gastrocnemius (102), 
indicating that the hypertrophic response in this rat strain may be muscle group- and/or 
fiber type-specific. Nevertheless, compensatory loading models induce significant 
increases in satellite cell proliferation, and it is widely debated whether or not satellite 
cell incorporation into myofibers is obligatory for muscle growth to occur following 
voluntary exercise (107). Therefore, it is difficult to compare the results of the current 
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study to previous research since different means were used to induce anabolism and to 
assess protein turnover.  
The most novel finding, in regards to the plasticity of myocellular sub-fractions 
following resistance exercise in gastrocnemius muscle, is that mitochondria appear to be 
desensitized to contractile activity in the insulin-resistant state. Long-standing metabolic 
disease is associated with morphological changes of mitochondria in humans (81) and 
obese Zucker rats (6), which potentially could alter the organelle‟s typical adaptive 
response to exercise (71). Menshikova (95) and Toledo (125) reported that chronic 
endurance training preferentially augments mitochondrial biogenesis in obese and type 2 
diabetic individuals by increasing surface area of the inner mitochondrial membrane 
(cristae), rather than inducing mitochondrial proliferation (mtDNA content), as typically 
seen in healthy subjects. Whether or not this differential adaptation in the insulin-
resistant state is attributed to an attenuated acute anabolic response, in terms of synthesis 
or import of mitochondrial proteins, is less clear. Since mitochondrial FSR, as measured 
in our study, represents 2H-alanine incorporation in both nuclear- and mtDNA-encoded 
proteins over a 24-h period, any defects in the replication, transcription, or translation of 
either genome could theoretically have attributed to a blunted exercise response in the 
obese phenotype. Considering that the vast majority of mitochondrial matrix and 
membrane proteins are encoded by nuclear DNA (only 13 out of ~1500 proteins are 
encoded by the organelle‟s own genome), in addition to the fact that replication, 
transcription, and translation of mtDNA are ultimately controlled by nuclear-encoded 
proteins (41), we believe that insulin resistance may be associated with multiple 
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dysfunctions in the manufacture and import of nuclear proteins, leading to a blunted 
anabolic response (i.e. mitochondrial FSR) following acute contractile activity.    
To our knowledge, the molecular mechanisms causing differential mitochondrial 
adaptations in obese and insulin-resistant individuals following exercise remain largely 
unknown. Since we were unable to measure signal transduction immediately following 
RE (~0-3 h post) due to the necessity of a 24-h 2H2O enrichment period, the intracellular 
events responsible for an attenuated increase in mitochondrial FSR will be elucidated in 
future studies. Mitochondrial biogenesis is thought to be highly dependent upon the 
activation of AMPK-regulated transcriptional coactivator PPARγ coactivator-1 (PGC1α) 
and its interaction with sequence-specific DNA binding proteins, mainly nuclear 
respiratory factors 1 and 2 (NRF-1/NRF-2). Previous research has indicated that acute 
muscle contractions do not stimulate AMPKα1 activity in obese Zucker rats, whereas the 
same contractile stimulus causes ~2-fold increase in AMPKα1 activity in lean rats (7). 
Although it is generally accepted that PGC1α is regulated by AMPK, PGC1α activation 
following acute exercise is not dependent upon either α1 or α2 isoforms of this enzyme 
(76). In further support of those findings, acute aerobic exercise amplifies PGC1α and 
NRF-1 mRNA expression in obese and type 2 diabetic subjects to the same extent as in 
lean individuals, despite a robust down-regulation of AMPK-signaling in the former 
(117). That same research group reported that obese Zucker rats are able to augment 
PGC1α protein expression equally well compared to their lean counterparts with chronic 
endurance exercise, although the obese phenotype exhibits a reduced expression of 
LKB1 and attenuated activation of AMPK (118). The underlying molecular mechanisms 
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are currently unknown, but LKB1 is a „master kinase‟ that regulates the activity of 13 
AMPK-related kinases and CaMK (in conjunction with calmodulin and intracellular 
Ca2+), all of which may compensate for the lack of contractile-induced stimulation of 
AMPK. MAPK signaling has also been shown to be necessary to release PGC1α from its 
competing repressor protein (p160MBP), but compared to lean humans and rodents the 
time-course and magnitude of ERK1/ERK2, p90RSK, and p38 phosphorylation 
following a single bout of contractile exercise is preserved or greater in their obese 
counterparts (27, 78, 88). Although cytosolic to nuclear abundances of PGC1α and 
SIRT-1 (or SIRT1-mediated deacetylation of the former) have not been assessed in 
exercise intervention studies, it appears that activation of PGC1α subsequent to physical 
activity is normal in the insulin-resistant state and may therefore not be responsible for 
altered mitochondrial adaptations. Numerous other transcription factors, corepressors, 
and coactivators have been implicated in mediating the anabolic response of 
mitochondria in concert with PGC1α, including yin-yang 1, peroxisome proliferator-
activated receptors (PPARα, PPARβ/δ, and PPARγ), RIP140, and PRC, but few 
comparative studies have been conducted to date. 
Calcium signaling through calcineurin, PKC, and CaMK are postulated to play 
significant roles in mitochondrial biogenesis since calcium-induced muscle contractions 
are ultimately dependent upon a steady energy supply from the organelle. The obese 
Zucker rat exhibits elevated intracellular Ca2+ levels and reduced Ca2+ ATP activity (89, 
90, 142), in addition to increased levels of intramuscular diacylglycerol and ceramide (5, 
127), which is associated with chronic activation/membrane translocation of 
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conventional [α and β] and novel PKCs [δ, ε, and θ] (5). Chronic activation of PKC (θ) 
is strongly linked to skeletal muscle‟s insulin resistance to glucose disposal (Lowell 
2005), but whether or not a constant basal activation of these enzymes dampens the 
ability to sense contractile-induced stimuli is unknown. A recent study reported a 
blunted augmentation in soleus muscle mass and fiber cross-sectional area following 
synergistic ablation in the obese Zucker rat, which was mirrored by an attenuated 
activation of calcineurin (59). Although the role of calcineurin in mitochondrial 
biogenesis have been questioned (55), these findings lend support to the notion that 
calcium-regulated enzymatic activity is attenuated in obese and insulin-resistant states. 
Lastly, emerging evidence for the role of the evolutionary conserved TOR pathway in 
the regulation of mitochondrial biogenesis (10, 26, 111) indicates that Raptor-mediated 
activation of mTOR is imperative to maintain mitochondrial morphology and function. 
Previous research has shown  that the obese Zucker rat exhibits a blunted activation of 
the Akt-mTOR-p70s6k pathway 1-3 h following high-force electrical stimulation, 
suggesting that global synthesis rates, including mitochondrial FSR, are attenuated 
compared to the lean phenotype (77). Considering that translation of the vast majority of 
mitochondrial proteins ultimately is under the control of TOR signaling, it makes 
intuitive sense that an alteration in this pathway could have a fundamental impact on 
mitochondrial FSR following exercise.   
Many of the metabolic aberrations associated with type 2 diabetes and obesity 
would be expected to cause abnormal protein turnover, but few studies have looked at 
the effect of obesity-induced insulin resistance on intracellular mechanisms governing 
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skeletal muscle growth (e.g., manufacture and degradation of proteins). Previous studies 
in type 2 diabetics have mainly focused on proximal muscle groups (e.g., quadriceps) 
despite documented peripheral vascular disease and neural dysfunction in distal limb 
regions of this population (110). Furthermore, assessments of protein turnover have 
typically been done on the mixed protein fraction, which is particularly problematic in 
metabolic disease conditions where subtle changes in synthesis/degradation of specific 
myocellular compartments may be masked in the total protein pool. Previous research in 
the obese Zucker rat has indicated that an increased rate of degradation (4) coupled with 
a reduced rate of protein synthesis (37) and suppressed satellite cell proliferation (102) 
collectively confer the atrophic phenotype in this rat strain. Nevertheless, most of the 
current knowledge pertaining to protein metabolism in this metabolic rodent model is 
limited to the mixed protein fraction and much less is known about the individual 
contribution of specific myocellular sub-compartments to the overall condition. Thus, an 
important goal of our study was to elucidate if insulin resistance is associated with 
uniform perturbations in FSR in regards to proximodistal location of muscle groups and 
biological function of various myocellular compartments (substrate metabolism 
[cytosol/mitochondria] vs. contractile activity [myofibrils]). As previously mentioned, 
we utilized a novel stable isotopic method that offers several methodological advantages 
over the traditional precursor-product techniques (flooding dose, in vitro incubation, and 
continuous infusion protocols). The most important distinction is that the 2H2O method 
allows for long-term assessments of biosynthesis rates in free living conditions, meaning 
that measurements can be done over long periods of time without perturbing normal 
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activity patterns (feeding and sleep) or introducing the muscle into an artificial 
environment (in vitro). Herein we provide evidence that basal protein synthesis rates in 
the insulin-resistant state are differentially affected depending upon proximodistal 
location of the muscle group. We demonstrate for the first time that 24-h fractional 
synthesis rates of mixed proteins in quadriceps muscle are significantly elevated in 
developmentally mature obese Zucker rats, but mildly suppressed in soleus and 
gastrocnemius. The latter results should be interpreted with caution since phenotypical 
differences in distal muscle groups were partially attributed to modest augmentations of 
mixed FSR following RE in the lean cohort. To our knowledge, there are no previously 
published reports on protein metabolism in isolated quadriceps muscle in this rat strain. 
Previous research has demonstrated that protein turnover of thigh muscles, which 
presumably included posterior flexor muscles, is lower in obese vs. lean rats and that this 
suppression becomes less marked with advancing age (106). Thus, although the obese 
phenotype may exhibit a significant repression of mixed protein synthesis rates in earlier 
developmental stages (106), the current study indicates that these perturbations disappear 
or even reverse when the animal reaches musculoskeletal maturity. A recent report 
involving human subjects supports the notion that basal protein synthesis and 
degradation rates are elevated in quadriceps muscle of obese subjects with poorly 
controlled type 2 diabetes (9), but more research is clearly needed to confirm these 
findings and elucidate underlying mechanisms. Considering that much less is known 
about the effects of human insulin resistance on protein metabolism in distal muscle 
groups such as the plantar flexors, most of our current knowledge have been inferred 
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from research completed in metabolic rodent models. The fact that the obese Zucker rat 
exhibits similar vascular and neural dysfunctions that are present in human obesity/type 
2 diabetic conditions makes it a particularly appealing candidate for studying the effects 
of insulin resistance on protein metabolism in distal muscle groups (99). Although our 
results generally corroborate earlier work that has assessed protein turnover in distal 
muscle groups in this rat strain (37, 47, 106), we extend previous observations by 
demonstrating that the suppression is less or non-existent in comparison to what has 
been previously reported, and when a suppression is observed, it is found in sub-
fractions involved in contractile function rather than substrate metabolism. In light of the 
observation that 24-h protein synthesis rates are significantly lower in the myofibrillar 
sub-fraction of the obese phenotype [gastrocnemius], and largely unaffected in 
mitochondrial and cytosolic compartments [gastrocnemius and quadriceps], we surmise 
that the metabolic syndrome is associated with a preferential down-regulation of 
contractile protein synthesis rates whereas manufacture of metabolic enzymes are 
maintained [or slightly elevated] to cope with nutrient excess.  
Perhaps the most interesting finding of this study is that basal mitochondrial FSR 
is not reduced in the gastrocnemius muscle (or quadriceps) of the obese phenotype, 
despite being unable to significantly augment rates of protein synthesis in this sub-
fraction in response to contractile activity. These results are supported by the fact that we 
did not find a phenotypic difference in mitochondrial protein content on a whole muscle 
level, which was attributed to a 31% increase in mitochondrial density in the obese 
cohort (Fig. 5BC). When adjusting protein synthesis rates for sub-fractional 
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concentrations, mitochondrial FSR was indeed elevated ~20% in the obese phenotype 
(Fig. 8F, insert). Our finding that the obese Zucker rat exhibited a robust augmentation 
in mitochondrial density in gastrocnemius muscle corroborates recent work by Holloway 
et al. (69), who reported a significant upregulation of COX-IV and mtDNA (+30% and 
+47%, respectively) in the same muscle group and rat strain. Although these values were 
reported as protein contents, protein expression obtained by Western blotting is 
technically a measure of protein concentration (expression/ug total protein loaded). The 
authors also found that mitochondrial oxidation rates, albeit significantly increased 
compared to the lean phenotype, are attenuated compared to rates of fatty acid transport, 
causing an increased esterification of fatty acids and intramuscular lipid accumulation 
(69). Bach and colleagues demonstrated that the obese Zucker rat exhibits smaller and 
misshapen mitochondria due to a dysregulation in mitochondrial fusion events 
(mitofusin-2), but total mitochondrial volume is normal since mitochondrial density is 
elevated compared to its lean counterpart (6). Taken altogether, these results lend 
support to the notion that mitochondrial dysfunctions per se, more specifically 
reductions in density, total content/volume, oxidation rates, and translational capacity 
(mtDNA), do not have to be present to induce intramuscular lipid accumulation and 
skeletal muscle insulin resistance. We extend these findings by showing that 
mitochondrial synthesis rates, which ultimately regulate biogenesis of the organelle, are 
not impaired in chronically obese states, but may be desensitized to contractile-induced 
stimuli.    
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To further elucidate differences in basal protein synthesis rates between 
phenotypes we performed studies focused on the expression of proteins known to 
regulate nuclear mRNA translation initiation and polypeptide elongation in 
gastrocnemius muscle. We found that the obese Zucker rat exhibits a reduced expression 
of Akt, mTOR, and Raptor, all of which are important upstream mediators of mRNA 
translation and polypeptide elongation. Considering that the Akt/mTOR pathway is up-
regulated during hypertrophy and down-regulated during muscle atrophy (11), it is not 
surprising that knockout models suffer from reduced growth and severe loss of muscle 
mass/function (10, 23, 98, 109). Although a suppressed Akt-mTOR-Raptor expression 
theoretically may attenuate rates of protein synthesis in the obese Zucker rat, our 
observation that phosphorylation states of downstream mTOR targets eIF4EBP1 
(eukaryotic initiation factor 4 binding protein) and p70s6k (p70 ribosomal protein S6 
kinase) are elevated does not support this notion. It is tempting to speculate that, 
although mTOR expression is suppressed in the obese phenotype, the activation of the 
enzyme may be constitutively increased compared to its lean counterpart. Although 
complexation/immunoprecipitation studies need to be completed to confirm this notion, 
several observations in literature support this concept. The current prevailing view is that 
mTOR regulates many fundamental biological processes by integrating both intracellular 
and extracellular signals, including growth factors (insulin) and nutrients (branched-
chain amino acids; BCAAs). A previous study demonstrated that the availability and 
concentrations of BCAAs (primarily leucine) are significantly elevated in hindlimb 
muscles of the obese Zucker rat (64). BCAAs are known to activate Rag GTPases, the 
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Ste-20 related kinase MAP4K3, and the class III PI3-K mVps 34, all of which mediate 
amino acid signaling to mTORC1 and promote p70s6k activation (58, 104). Chronic 
stimulation of p70s6k induces insulin resistance through a negative feedback loop upon 
IRS-1 [pSer 307, pSer 636/639] and knockout models have further corroborated p70s6k 
role in the development of metabolic disease by showing that its deletion protects against 
diet-induced obesity and improves insulin sensitivity (128). Thus, it is possible that 
nutrient overload in the obese phenotype facilitates a constitutively higher level of Akt-
independent mTOR activation, leading to a more pronounced phosphorylation of 
downstream targets of mTOR and insulin resistance. Although it may appear perplexing 
that an augmented phosphorylation of eIF4EBP1 and p70s6k is not mirrored by an 
elevation in global protein synthesis rates in the obese phenotype, we found that 
sedentary obese rats exhibited a more potent deactivation of peptide chain elongation 
compared to lean rats. In support of our findings, recent research has shown that ob/ob 
mice exhibit a greater repression in global rates of muscle mRNA translation compared 
to wild type mice, despite increased activation of p70s6k/rpS6/eIF4EBP1 and reduced 
raptor-associated mTOR (138). Another plausible explanation is that up- or down-
regulation of nuclear translation/elongation steps may preferentially target specific 
compartments of the muscle cell, although an increased/decreased translational 
efficiency of specific mRNA pools is yet to be proven. This would be a particularly 
appealing adaptive mechanism whereby the obese Zucker rat is able to maintain normal 
cytosolic and mitochondrial protein synthesis rates in response to an elevated 
intramuscular lipid load, but at the expense of myofibrillar FSR.  
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Our results demonstrate that the anabolic response of insulin-resistant skeletal 
muscle is blunted following voluntary resistance exercise, and that the effects of insulin 
resistance on cumulative protein synthesis rates are divergent and dependent upon 
myocellular sub-fraction and proximodistal location of the muscle group. We 
acknowledge that physiological adaptations to exercise are intensity-dependent and that 
obese Zucker rats are inherently inactive. In our hands, the obese phenotype mastered 
the movement pattern equally well compared to its lean counterpart and did not require 
an altered absolute exercise intensity or increased negative reinforcement. We believe 
that we promoted an anabolic response in exercised obese rats since phospho/total 
eIF4EBP1 was significantly elevated following resistance exercise when compared to 
sedentary counterparts and even augmented in comparison to the corresponding lean 
group (Fig. 10). Although the mitochondrial response was blunted in gastrocnemius 
muscle, a 12% increase in FSR of this organelle further supports a modest anabolic 
effect in the obese phenotype. The lean rats exhibited a potent augmentation of 
myofibrillar and cytosolic FSR in quadriceps muscle (+40% and +17%, respectively), in 
addition to the already discussed outcomes in mixed gastrocnemius muscle. Although 
unaccustomed exercise may induce muscle damage (91), our progressive RE protocol 
did not promote significant edema as evidenced by no change in wet mass or total 
protein concentrations in either phenotype at the end of the study (Fig. 5-6). 
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CHAPTER III 
SUMMARY AND CONCLUSIONS 
In summary, we provide evidence that protein synthesis of mixed muscle 
homogenates is similar in lean and obese rats, even though the obese phenotype exhibits 
markedly lower muscle mass. While it is tempting to consider that differences in muscle 
mass must be due to an elevated rate of protein degradation or reduced satellite cell 
differentiation, this study offers an exciting alternative possibility. While mixed 
synthesis rates may be similar between phenotypes, the manufacture of specific sub-
fractions of the cell may be very different. For example, our data strongly suggests that 
24-h protein synthesis rates are near normal (and sometimes augmented) in cellular 
compartments containing oxidative and glycolytic enzymes [mitochondria and cytosol], 
but may be relatively repressed in sub-fractions involved in energy utilization and 
muscle contraction [myofibrils] depending upon proximodistal location of the muscle 
group. To our knowledge, this study was the first to demonstrate that insulin resistance is 
not associated with reductions in density or synthesis rates of mitochondrial proteins in 
gastrocnemius or quadriceps muscles of the obese Zucker rat, perhaps at the expense of 
the contractile apparatus. Although at present we cannot provide the underlying 
mechanism(s), it is clear that this fraction-specific phenotypical suppression cannot be 
explained by a reduced expression/activity of proteins in the Akt/mTOR pathway, since 
basal phosphorylation of downstream translation initiation factors are augmented in the 
obese vs. lean phenotype. We surmise that steps involved in polypeptide elongation are 
more strongly controlled in obese rats, or that translational capacity (total mRNA and/or 
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ribosome content) and/or translational efficiency (number of transcripts translated for 
any given mRNA/ribosome content) of specific mRNA pools are altered to cope with 
nutrient overload. Whether translation of specific mRNA pools are determined 
exclusively by the availability of transcripts and/or if there is a preferential regulation of 
what transcripts are targeted for translation remain to be elucidated.  
Although exercise is commonly prescribed to reduce whole-body glycemia in 
type 2 diabetics, the optimal type, frequency, intensity, and duration to achieve 
therapeutic goals are not known. The current study demonstrates a blunted anabolic 
response in myofibrillar, cytosolic, and mitochondrial sub-fractions following acute 
resistance exercise in the insulin-resistant state, suggesting that alternative 
implementation strategies of traditional RE protocols may be necessary for insulin-
resistant individuals to achieve similar gains in muscle growth as healthy subjects. Taken 
together, these findings underscore the importance of assessing synthesis rates of 
specific sub-fractions or individual proteins to fully elucidate the subtle differences in 
protein turnover associated with insulin resistance, and to determine the intracellular 
mechanisms underlying a differential anabolic response to exercise in insulin-resistant 
skeletal muscle.   
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